Human fibrinogen database

Groupe d'etude sur l'hemostase et la thromboseHuman fibrinogen database
Fibrinogen variants : A𝜶 chain Fibrinogen variants : B𝜷 chain Fibrinogen variants : 𝜸 chain

Last update : 31/12/2023 release 54
GenBank access number : NG_008832.1

This update is partial
Z. Sovova, MSc, PhD, should be acknowledged for her valuable assistance.

Abnormality
Plasma protein N-19 Native protein N Gene (as reported) e-i Gene status Name / Origin Type Haemorraghes Thromboses Authors
Aα(-19) M1L c.1A>T e-1 compound MADAGASCAR a Yes No Tirefort Y et al. 2012
Aα(-19)Met>Val p.Met1Val e-1 compound USA 1 hd Yes No Smith N et al. 2018
  g.773: 4.1 kb del e-1 compound ITALY, P1 = FLORENCE, F5 a Yes       Monaldini L et al. 2007      
   -1138C>T e-1     HAMAMATSU h Okumara N et al. 2000  A
Aα(-18)>frameshift-stop 34insC e-1 compound BELGIUM A8 a Neerman-Arbez M et al. 2000
Aα(-14)Ile>Val I6V c.16A>G e-1 compound MADAGASCAR a Yes No Tirefort Y et al. 2012
" AαIle6Val c.16A>G e-1 compound BAISE h Yes No Zhou W et al. 2018
" 6Ile>Val c.16A>G e-1 compound Family 2 d No No Wan Y et al. 2021
" c.16A>G e-1 heterozyg CHINA 20 h Yes No Zhou P et al. 2021
Aα(-12) c.22_30delTGCCTGGTC e-1 homozyg INDIA P1, P4 a Yes Mukaddam A et al. 2015
Aα(-11) p.Cys8stop g.54C>A e-1 homozyg PAKISTAN P5 a Yes No Asselta R et al. 2015
Aα(-2)                   
11 kb deletion i-1 homozyg GENEVA (4 cases) a Neerman-Arbez M et al. 1999
     11 kb deletion i-1 compound FRANCE, A3 a           Neerman-Arbez M et al. 2001     
     11 kb deletion i-1 homozyg FRANCE, C5 a           Neerman-Arbez M et al. 2001     
11 kb deletion i-1 compound KINGSPORT a           Galanakis DK et al. 2007    
     11 kb deletion i-1 compound SWITZERLAND, B6 a           Neerman-Arbez M et al. 2001     
     11 kb deletion i-1 homozyg SWITZERLAND, B7 a           Neerman-Arbez M et al. 2001     
     11 kb deletion i-1 homozyg SWITZERLAND, C3 a           Neerman-Arbez M et al. 2001     
11 kb deletion i-1 compound UNITED STATES, B4 a Neerman-Arbez M et al. 2000
 IVS1+1G>A i-1 homozyg R99 a  Yes  (No) Monaldini L et al. 2005
 IVS1+3A>G i-1 compound FRANCE, A10 a Neerman-Arbez M et al. 2000
c.54+3A>C i-1 compound KURASHIKI II a Yes No Takezawa Y et al. 2012
Aα(-1)                        
Aα(-1-41) del c.169_180+2 del e-2 heterozyg SHANGAI (n=2) d No Yes Zhou J et al. 2016
Aα(7)Asp>Asn     LILLE      No No Morris S et al. 1981 A
Aα(8)Phe>Cys      T>G e-2               No No Mumford AD et al. 2001 A
" p.Phe27Cys c.80T>G e-2 heterozyg UNITED KINGDOM (2 cases) d No Shapiro SE et al. 2013
Aα(8)Phe>Tyr p.Phe27Tyr e-2 P9 d Yes No Marchi R et al. 2021
Aα(9)Leu>Pro      1182T>C e-2     MAGDEBURG No No Meyer M et al. 2003
" p.Leu28Pro c.83T>C e-2 heterozyg TAIWAN 6 (n=6) d No No Shen MC et al. 2021
Aα(11)Glu>Gly heterozyg MITAKA II      Yes No Niwa K et al. 1993
" A>G e-2                   Meyer M et al. 2000 A
Aα(11)Glu del p.E30del c.88_90del e-2 heterozyg SOKA d No No Kaido T et al. 2020
Aα(12)Gly>Val     ROUEN      Yes No Henschen A et al. 1983 L
" G>T e-2     SAINT GERMAIN No No Mathonnet F et al. 2002
" Gly31Val c.92C>T e-2 heterozyg MULTINATIONAL d Yes No Casini A et al. 2015
Aα(12)Gly>Glu p.Gly31Glu c.92G>A e-2 heterozyg Chinese d Wang X et al. 2019
" (p.Gly31Glu) c.92G>A e-2 heterozyg ZHENGZHOU d No No Qiao Y et al. 2020
Aα(13)Gly>stop 1193G>T e-2 compound ITALY, P1 = FLORENCE, F5 a Yes No Asselta R et al. 2001
Aα(13)Gly>Arg 1223G>C e-2 heterozyg NANNING (n=4) d Yes No Yan J et al. 2016
Aα(13)Gly>Glu     HANNOVER XXV Czwalinna A 2004 O
" 4864G>A e-2 heterozyg OLOVNICE Yes Kotlín R et al. 2011
" Gly32Glu c.95G>A e-2 heterozyg KRAKOW II (2 cases) Yes Pietrys D et al. 2011
" g.3447G>A e-2 compound SUMPERK II d Yes No Kotlin R et al. 2012
" p.Gly32Glu c.95G>A e-2 heterozyg SLOVAKIA F2 (n=3) d Yes/No No Simurda T et al. 2020
" p.Gly32Glu c.95G>A e-2 heterozyg SLOVAKIA F3 (n=3) d Yes No Simurda T et al. 2020
Aα(14)Gly del p.Gly33del g.6225-27AGGdel e-2 ? Chinese d No No Zhou J et al. 2015
Aα(15)Val>Glu T>A e-2             Meyer M et al. 2000 A
Aα(16)Arg>Cys     AMSTERDAM      No No Henschen A et al. 1984
"     BERGAMO      No No Reber P et al. 1985
"     BERN III      No No Furlan M et al. 1991
"     BERN V      Yes No Stücki B et al. 1999
" CGT>TGT e-2     BRAUNSCHWEIG      No Yes Meyer M et al. 2000 A
" e-2 heterozyg Chinese Ouyang Q et al. 2011
" p.Arg35cys c.103C>T e-2 heterozyg DALLAS d?, fsd No Lee MJ et al. 2015
" CGT>TGT e-2     ERFURT      No No Meyer M et al. 2000 A
" CGT>TGT e-2     ERLANGEN      Yes No Meyer M et al. 2000 A
" CGT>TGT e-2     ERLANGEN II      No No Meyer M et al. 2000 A
" CGT>TGT e-2     ERLANGEN III      Yes No Meyer M et al. 2000 A
" CGT>TGT e-2     ERLANGEN IV      No Yes Meyer M et al. 2000 A
"     FRANKFURT II      Yes No Henschen A et al. 1984
"     FRANKFURT III      Yes No Henschen A et al. 1984
"     FRANKFURT V      No Yes Haverkate F et al. 1995
" heterozyg FRANKFURT VI (n=3) - - Miesbach W et al. 2009
" heterozyg FRANKFURT X (n=3) Yes Miesbach W et al. 2009
" heterozyg FRANKFURT XII (n=2) Yes Miesbach W et al. 2009
" heterozyg FRANKFURT XIII      No No Galanakis D et al. 1993
" homozyg FRANKFURT XIII (n=2) Yes Yes Miesbach W et al. 2009
" heterozyg FRANKFURT XVI (n=3) Yes Miesbach W et al. 2009
"    compound FREIBURG Czwalinna A 2004  O
"     GENEVA      No No Furlan M et al. 1990
" CGT>TGT e-2     GIESSEN IV      Yes No Meyer M et al. 2000 A
" CGT>TGT e-2     HANNOVER III      No No Meyer M et al. 2000 A
" CGT>TGT e-2 HANNOVER VIII                Czwalinna A et al. 2001 A
"        HANNOVER XXVIII             Czwalinna A 2004 O
" CGT>TGT e-2 HERSHEY II      No Yes Galanakis DK et al. 1990 L
" CGT>TGT e-2     HERSHEY III      Yes Flood VH et al. 2006
"     HOMBURG II      No No Miyashita C et al. 1985 L
" HOMBURG III      Yes No Miyashita C et al. 1985 L
" CGT>TGT e-2     JENA      No No Meyer M et al. 2000 A
" 1202C>T e-2 KAISERSLAUTERN III      Yes No Loreth RM et al. 2001 A
"     KAWAGUCHI      No No Matsuda M et al. 1986 L
"     LEDYARD      Yes No Lee MH et al. 1991
" CGT>TGT e-2 LEOGAN      No No Galanakis DK et al. 1990 L
"     LONDON III      No No Lane D et al. 1987
"     LONDON VI      Lane D et al. 1987
" METZ      Yes No Soria J et al. 1982 L
" 1202C>T e-2     MILANO XII No No Bolliger-Stücki B et al. 2001
" 6232C>T e-2 heterozyg NANNING d No Yes Luo M et al. 2018
" C>T e-2     NORTHSPRING      Yes 2 Galanakis D et al. 2003 A
" heterozyg NOVY JICIN Yes Kotlin R et al. 2007
"     OSAKA      No No Matsuda M et al. 1986 L
" 3455C>T e-2 heterozyg OSTRAVA II No No Kotlin R et al. 2010
"     OVIADO II or MADRID II      No No Lane D et al. 1987
"     SCHWARZACH      No No Henschen A et al. 1983 L
"     STONY BROOK      No No Galanakis D et al. 1989
"     TORINO      No No Reber P et al. 1987
"     ZÜRICH      No No Henschen A et al. 1983 L
" p.Arg35Cys c.103C>T e-2 heterozyg UNITED KINGDOM ( 2 cases) d Yes No Shapiro SE et al. 2013
" Arg35Cys c.103C>T e-2 heterozyg MULTINATIONAL (9 cases) d Yes Yes Casini A et al. 2015
" p.Arg35Cys g.6232C>T e-2 ? Chinese (16 cases) d Yes No Zhou J et al. 2015
" p.Arg35Cys e-2 heterozyg USA 17 hd No No Smith N et al. 2018
" p.Arg35Cys e-2 compound USA 18 hd Yes No Smith N et al. 2018
" Arg35Cys e-2 Serbian (9 cases) d No No Castaman G et al. 2019
" p.Arg35Cys c.103C>T e-2 heterozyg HUNGARY 1 d Yes No Gindele R et al. 2021
" p.Arg35Cys e-2 P8 (n=2) d No No Marchi R et al. 2021
" c.103C>T e-2 heterozyg CHINA 2 d Yes No Zhou P et al. 2021
" c.103C>T e-2 heterozyg CHINA 3 d No No Zhou P et al. 2021
" c.103C>T e-2 heterozyg CHINA 4 d No No Zhou P et al. 2021
" c.103C>T e-2 heterozyg CHINA 16 hd No No Zhou P et al. 2021
" p.Arg35Cys c.103C>T e-2 heterozyg IRAN 6 d Yes No Mohsenian S et al. 2021
Aα(16)Arg>His     AMIENS      Soria J et al. 1987 L
"     AMIENS II            Soria J et al. 1987
"     BARCELONA II      Yes No Borrel M et al. 1990   
"     BERGAMO III      No No Reber P et al. 1987
"     BERN II      No No Rupp C et al. 1983
"     BERN IV      No No Stücki B et al. 1999
"     BICÊTRE      Henschen A et al. 1983 L
"     BIRMINGHAM      Yes No Siebenlist KR et al. 1988
"     CHAPEL HILL II      Yes No Carrell N et al. 1985 L
" c.104G>A e-2 heterozyg Chinese II (I-1) d No No Luo M et al. 2016
" c.104G>A e-2 heterozyg Chinese II (II-2) d No No Luo M et al. 2016
" c.104G>A e-2 heterozyg Chinese II (III-3) d No No Luo M et al. 2016
" G1233A e-2 heterozyg Chinese (4 cases) d Zhang YL et al. 2017
" 1233C>A e-2 heterozyg GUANGXI (4 cases) d No No Yan J et al. 2017
" CGT>CAT e-2     KAISERSLAUTERN II      Yes No Loreth RM et al. 1997 A
"     CLERMONT-FERRAND      Soria J et al. 1985 L
"     GIESSEN      Yes No Alving BM et al. 1987
" KENDAL      Lane DA et al. 1987 L
"     KIEL      No No Seydewitz HH et al. 1991
" G>A e-2 compound KINGSPORT Galanakis DK et al. 2007
"     LEITCHFIELD      Henschen A et al. 1984 L
"     LONDON      No No Mitchell M et al. 2002 A
"        LONDON VII       Lane D et al. 1987
"     LONG BEACH      Pirkle H et al. 1987 A
"     LOUISVILLE      Yes No Galanakis DK et al. 1983
" CGT>CAT e-2     LÜBECK      No No Meyer M et al. 2000 A
" CGT>CAT e-2     MANCHESTER      No No Southan C et al. 1983
"     MILANO IV      No No Bögli C et al. 1992
"     MILANO VI      Yes No Bögli C et al. 1990
"     MILANO XI      No No Stücki B et al. 1999
"     NEW ALBANY      No No Henschen A et al. 1983 L
" CGT>CAT e-2     NEW BRITAIN      No No Webb CD et al. 1994
"     OSAKA IV      No No Yamazumi K et al. 1993
" 3456G>A e-2 heterozyg OSTRAVA No No Kotlin R et al. 2010
"     PARIS VI      Southan C et al. 1987
"     PETOSKEY      No No Higgins DL et al. 1981
" CGT>CAT e-2     POISSY      No Yes 1 Mathonnet F et al. 1997
" CGT>CAT e-2     POISSY III      Mathonnet F et al. 2001
" heterozyg PRAHA II       Kotlin R et al. 2007   
"     SAPPORO      No No Asakura S et al. 1989
" SEATTLE II      No No Ebert RF et al. 1986
"     SHEFFIELD      Yes No Southan C et al. 1987
"     STONY BROOK II      Yes No Galanakis DK et al. 1990
"     SYDNEY      No No Southan C et al. 1985 L
"     SYDNEY II      Southan C et al. 1985 L
" CGT>CAT e-2     TAHITI           Mathonnet F et al. 2001
"     WHITE MARSH      Carr ME et al. 1987
" c.104G>A e-2 heterozyg KRAKOW IV d Yes No Zdziarska J et al. 2011
" p.Arg35His c.104G>A e-2 heterozyg UNITED KINGDOM d No No Shapiro SE et al. 2013
" p.Arg35His c.104G>A e-2 heterozyg UNITED KINGDOM d No No Shapiro SE et al. 2013
" p.Arg35His c.104G>A e-2 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
" p.Arg35His c.104G>A e-2 heterozyg UNITED KINGDOM d Yes Yes Shapiro SE et al. 2013
" p.Arg35His c.104G>A e-2 heterozyg UNITED KINGDOM d No Yes Shapiro SE et al. 2013
" p.Arg35His c.104G>A e-2 heterozyg UNITED KINGDOM d No No Shapiro SE et al. 2013
" c.104 G>A e-2 heterozyg TOKYO (2 cases) d No No Imamura H et al. 2013
" Arg35His c.104G>A e-2 heterozyg MULTINATIONAL (14 cases) d Yes Yes Casini A et al. 2015
" e-2 heterozyg SOUTH ITALY D1 d No No Santacroce R et al. 2006
" p.Arg35His g.6233G>A e-2 ? Chinese (19 cases) d Yes No Zhou J et al. 2015
" p.Arg35His e-2 heterozyg USA 13 d Yes No Smith N et al. 2018
" p.Arg35His e-2 heterozyg USA 14 d Yes No Smith N et al. 2018
" p.(Arg35His) c.104G>A e-2 heterozyg SURESNES II d Yes No Vasse M et al. 2019
" p.(Arg35His) c.104G>A e-2 heterozyg SURESNES III d No No Vasse M et al. 2019
" Arg35His e-2 Italian (4 cases) d Yes Yes Castaman G et al. 2019
" p.Arg35His c.104G>A e-2 heterozyg CANADA d Yes No Kumar K et al. 2021
" Arg35His 1233G>A e-2 compound Family 1 d No No Wan Y et al. 2021
" Arg35His 1233G>A e-2 compound Family 2 d No No Wan Y et al. 2021
" p.Arg35His c.104G>A e-2 heterozyg HUNGARY 2 (n-5) d No No/Yes Gindele R et al. 2021
" p.Arg35His c.104G>A e-2 heterozyg HUNGARY 3 (n=3) d Yes No Gindele R et al. 2021
" p.Arg35His c.104G>A e-2 heterozyg HUNGARY 4 d No No/Yes Gindele R et al. 2021
" p.Arg35His c.104G>A e-2 heterozyg HUNGARY 5 d Yes Yes Gindele R et al. 2021
" p.Arg35His c.104G>A e-2 heterozyg SLOVAKIA F1 (n=16) d Yes/No No Simurda T et al. 2020
" p.Arg35His c.104G>A e-2 heterozyg SLOVAKIA F4 (n=2) d Yes/No No Simurda T et al. 2020
" p.Arg35His c.104G>A e-2 heterozyg SLOVAKIA F6 (n=2) d Yes/No No Simurda T et al. 2020
" p.Arg35His c.104G>A e-2 heterozyg SLOVAKIA F7 d Yes No Simurda T et al. 2020
" p.Arg35His c.104G>A e-2 heterozyg IRAN 3 d Yes No Mohsenian S et al. 2021
" p.Arg35His c.104G>A e-2 heterozyg IRAN 5 d Yes No Mohsenian S et al. 2021
" p.Arg35His e-2 P1 d No No Marchi R et al. 2021
" p.Arg35His e-2 P2 d No No Marchi R et al. 2021
" p.Arg35His e-2 P3 (n=2) d No No Marchi R et al. 2021
" p.Arg35His e-2 P4 (n=2) d Yes/No No Marchi R et al. 2021
" p.Arg35His e-2 P5 d Yes No Marchi R et al. 2021
" p.Arg35His e-2 P6 d Yes No Marchi R et al. 2021
" p.Arg35His e-2 P7 d Yes No Marchi R et al. 2021
" p.Arg35His c.104G>T ? e-2 heterozyg CHINA 1 d No No Zhou P et al. 2021
'' p.Arg35His c.104G>A e-2 heterozyg POLAND d No No Weronska A et al. 2022
'' p.Arg35His c.104G>A e-2 heterozyg CHINA (n=2) d No No Chen X et al. 2022
'' p.Arg35His c.104G>A e-2 heterozyg CHINA (n=2) d No No/yes Meng D et al. 2022
'' p.Arg35His 6233G>A e-2 heterozyg CHINA (n=4) d Liao XC et al. 2023
Aα(16)Arg>Ser e-2 heterozyg FRANKFURT XI Miesbach W et al. 2009
" p.Arg35Ser c.103C>A e-2 heterozyg UNITED KINGDOM (4 cases) d No No Shapiro SE et al. 2013
" p.Arg35Ser c.103C>A e-2 heterozyg UNITED KINGDOM (2 cases) d Yes No Shapiro SE et al. 2013
" p.Arg35Ser c.103C>A e-2 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
" Arg35Ser c.103C>A e-2 heterozyg MULTINATIONAL d Yes No Casini A et al. 2015
" p.Arg35Ser g.6232C>A e-2 ? CHINA (3 cases) d No No Zhou J et al. 2015
" Arg35Ser c.103C>A e-2 heterozyg SHENZHEN (3 cases) d Yes Yes Zhou J et al. 2017
" Arg35Ser c.103C>A e-2 heterozyg BRISTOL d No No Peck RC et al. 2021
" Arg35Ser c.103C>A e-2 compound BRISTOL d Yes No Peck RC et al. 2021
" c.103C>A e-2 heterozyg CHINA 5 d No No Zhou P et al. 2021
" c.103C>A e-2 heterozyg CHINA 6 d Yes No Zhou P et al. 2021
" c.103C>A e-2 heterozyg CHINA 7 d No No Zhou P et al. 2021
Aα(16)Arg>Pro p.Arg35Pro c.104G>C e-2 heterozyg UNITED KINGDOM (2 cases) d Yes No Shapiro SE et al. 2013
" p.Arg35Pro c.104G>C e-2 heterozyg UNITED KINGDOM (2 cases) d Yes No Shapiro SE et al. 2013
" p.Arg35Pro c.104G>C e-2 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
Aα(17)Gly>Cys c.106G>T e-2 compound AUSTIN d No No Brennan SO et al. 2015   
Aα(17)Gly>Ser p.Gly36Ser c.106G>A e-2 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
Aα(17)Gly>Asp Gly36Asp c.107G>A e-2 heterozyg GENEVA II (5 cases) d Yes No Casini A et al. 2014
" Gly36Asp c.107G>A e-2 heterozyg MULTINATIONAL (2 cases) d Yes No Casini A et al. 2015
Aα(17)Gly>Val e-2 heterozyg BREMEN d Yes No Wada Y et al. 1993
" c.107G>T e-2 heterozyg CHINA 8 hd Yes No Zhou P et al. 2021
Aα(18)Pro>Leu e-2 heterozyg KANAZAWA d No No Uotani C et al. 1990
" e-2 heterozyg KYOTO II (2 cases) d Yes No Yoshida N et al. 1991
" e-2 heterozyg CHINESE Ouyang Q et al. 2011
" p.Pro37Leu g.6239C>T e-2 ? CHINESE (2cases) d Yes No Zhou J et al. 2015
Aα(19)Arg>Ser e-2     DETROIT d Yes No Blombäck M et al. 1968
" g.1213G>C e-2 heterozyg P6, CHINESE d Yes No Wang Y et al. 2018
" p.Arg38Ser c.116G>C ? e-2 heterozyg HUNGARY 6 (n=2) d No No Gindele R et al. 2021
Aα(19)Arg>Asn e-2     MUNICH      Yes No Henschen A et al. 1983 L
Aα(19)Arg>Gly e-2 homozyg AARHUS d No Yes Blömback B et al. 1988 L
" e-2     KUMAMOTO d No Yes Yamaguchi SI et al. 1997
" e-2 heterozyg MANNHEIM (3 cases) d Yes Yes Dempfle CEH et al. 1990 L
" 1211 A>G e-2 heterozyg MATSUMOTO V d No No Tanaka H et al. 2001
" 1212 A>G e-2 heterozyg MILANO XIII (8 cases) d Yes Yes Bolliger-Stücki B et al. 1999
" AGG>GGG e-2 heterozyg OSLO IV d No No Brennan SO et al. 1997   
" Arg38Gly c.112A>G e-2 heterozyg MULTINATIONAL (4 cases) d Yes Yes Casini A et al. 2015
" p.Arg38Gly g.1211A>G e-2 heterozyg ITALY P5 h Yes No Asselta R et al. 2015
" p.Arg38Gly g.1211A>G e-2 heterozyg ITALY P6 h Yes No Asselta R et al. 2015
" p.Arg38Gly g.6241A>G e-2 ? Chinese (4 cases) d Yes No Zhou J et al. 2015
" Arg38Gly e-2 Italian (2 cases) d No No Castaman G et al. 2019
Aα(19)Arg>Trp p.R38W c.112A>T e-2 heterozyg BEIJING P1 d Yes No Cao Z et al. 2019
Aα(19)Arg>Thr AαArg38Thr c.113G>C e-2 heterozyg SHANDONG d No No Cai R et al. 2018
" p.Arg38Thr c.113G>C e-2 heterozyg IRAN 1 d No No Mohsenian S et al. 2021
" p.Arg38Thr c.113G>C e-2 heterozyg IRAN 2 d Yes No Mohsenian S et al. 2021
" p.Arg38Thr c.113G>C e-2 heterozyg IRAN 7 d No No Mohsenian S et al. 2021
" p.Arg38Thr c.113G>C e-2 heterozyg IRAN 8 d Yes No Mohsenian S et al. 2021
" p.Arg38Thr c.113G>C e-2 heterozyg P1 d Yes No Tavasoli B et al. 2020
Aα(20)Val>Asp GTT>GAT e-2 heterozyg CANTERBURY hd Yes No Brennan SO et al. 1995   
" p.Val39Asp c.116T>A e-2 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
Aα(20)Val>frameshift31aa-stop 1215delT e-2 compound ROME R3 a Yes No Asselta R et al. 2001   
"      g.1185delT e-2 compound FRANCE A3 a    Neerman-Arbez M et al. 2001
" 1215delT e-2 compound GEELONG a Yes No Saravanan L et al. 2008   
" e-2 homozyg SOUTH ITALY A1 a Yes Santacroce R et al. 2006
Aα(21)Val>frameshift-stop Val40TrpfsX31 g.1215delT; c.116 delT e-2 compound ITALY P2 (Palermo) a Yes Monaldini L et al. 2007   
" p.(Val40TrpfsTer31) c.117delT e-2 compound CALGARY a Yes Yes Nathoo N et al. 2018
" c.117delT e-2 compound LOS ANGELES, S3 a Yes No Young GA et al. 2018
'' p.Val40Trpfs*31 c.117delT e-2 homozyg ALGERIA (7 families) a Hadjali-Saichi S et al. 2022
'' p.Val40Trpfs*31 c.117delT e-2 compound ALGERIA (f8) a Hadjali-Saichi S et al. 2022
Aα(22)Glu>Lys p.Glu41Lys c.121G>A e-2 heterozyg ITALY P2 h Yes No Chinni E et al. 2018
Aα(33)Trp>stop p.Trp52X e-2 compound USA 18 hd Yes No Smith N et al. 2018
p.Trp52stop c.156G>A e-2 homozyg IRAN 14 a Yes No Mohsenian S et al. 2021
p.Trp52Ter c.156G>A e-2 homozyg P2 a Yes No Tavasoli B et al. 2020
p.Trp52Ter c.156G>A e-2 homozyg P3 a Yes No Tavasoli B et al. 2020
p.Trp52Ter c.156G>A e-2 homozyg P4 a Yes No Tavasoli B et al. 2020
Aα(36)Cys>Gly p.Cys55Gly g.6292T>G; c.221T>G e-2 heterozyg LA SEYNE h Yes No Hanss M et al. 2011
" p.Cys55Gly g.6292T>G; c.221T>G e-2 heterozyg QUIMPER h Yes No Hanss M et al. 2011
Aα(36)Cys>Arg p.Cys55Arg g.6292T>G; c.221T>C e-2 heterozyg MARSEILLES h No Yes Hanss M et al. 2011
" p.Cys55Arg g.1262T>C e-2 heterozyg ITALY P14 h? No No Asselta R et al. 2015
Aα(38)Asp>frameshift p.Asp57fs g.6298-6311del e-2 ? CHINESE (2 cases) d Yes Zhou J et al. 2015
Aα(39)Glu>Lys (p.Glu58Lys) c.172G>A e-2 heteroz BOE II No No Wang X et al. 2020
" (p.Glu58Lys) c.172G>A e-2 homozyg BOE II d Yes No Wang X et al. 2020
Aα(41)Trp>stop p.Trp59stop c.G180A e-2 homozyg INDIA P8, P14 h Yes Mukaddam A et al. 2015
Aα(41)                      
IVS2-G>A i-2 homozyg IRAN (2 cases) a Yes No Moazzeni A et al. 2023
   IVS2+1G>C i-2 heterozyg CHINESE h No No Chen H et al. 2008
   IVS2+1G>T i-2 heterozyg FREIBURG II h Czwalinna A 2004 O
c.180+1G>A i-2 heterozyg CHINA (n=4) hd Yes No Li Z et al. 2022
   c.180+2T>C i-2 heterozyg POLAND h Yes Neerman-Arbez M et al. 2007
IVS2+3insCAT i-2 heterozyg MONTPELLIER II (3 cases) hd Yes Yes Vorjohann S et al. 2010
c.181-2A>T i-2 heterozyg CZECH Rep d Louzil J et al. 2022
Aα(42)       
Aα(45)Cys>Phe g.1749G>T e-3 heterozyg CREMONA h  No No  Platè M et al. 2008
Aα(45)Cys>Gly (p.Cys64Gly) c.190T>G e-3 compound chinese h? No No Wang X et al. 2020
Aα(45)Cys>Tyr p.Cys64Tyr g.6780G>A; c.249G>A ? e-3 heterozyg MARSEILLE II Yes No Hanss M et al. 2011
'' p.Cys64Tyr c.191G>A e-3 heterozyg LOURES Yes Yes3 Watts Soares AW et al. 2020
Aα(47)Ser>frameshift-stop    1754-1755insT e-3 homozyg R76 a Yes No  Monaldini L et al. 2005
" c.196 delT e-3 homozyg Turkish a Yes No Aydin Köker S et al. 2020
Aα(47)Ser>frameshift-stop p.Ser66Phefs*10 c.196_197insT e-3 homozyg IRAN a Yes No Moazzeni A et al. 2023
Aα(51)Met>Arg 1767T>G e-3 compound ROME R3 a Yes No Platé M et al. 2007
Aα(58)Val>ProLeuMet-stop p.Val77delins ProLeuMetX c.229_231del3ins 12 e-3 homozyg IRAN P6 (Shiraz) a Yes Monaldini L et al. 2007
Aα(68)Lys>Gln p.K87Q c.259A>C e-3 heterozyg TEL AVIV d No Yes Salomon O et al. 2019
Aα(68)>frameshift-stop p.Lys87Asnfs*19 c.261delG e-3 homozyg ALGERIA (f9, f10) a Hadjali-Saichi S et al. 2022
Aα(69)Leu>His L88H T>A e-3 heterozyg SAN DIEGO IV Yes Morris TA et al. 2009
Aα(76)Tyr>stop Y95X      e-3 homozyg LEBANON, C6 a Neerman-Arbez M et al. 2001   
Aα(80)Asn del      1852-1854del e-3     CARACAS VI Yes Yes Marchi RC et al. 2004    
Aα(91)Met>Thr p.(Met110Thr) c.329 T>C e-3 heterozyg SURESNES IV d No Yes Vasse M et al. 2019
Aα(95)Arg>Lys Arg114Lys e-3 homozyg Italian (6 cases) d No No Castaman G et al. 2019
" Arg114Lys e-3 heterozyg Italian d? No No Castaman G et al. 2019
" p.(Arg114Lys) c.341 G>A e-3 heterozyg Turkish d? No yes Vasse M et al. 2019
Aα(100)Ser>stop 1914C>G e-3 homozyg IRAN I3 a Yes No Asselta R et al. 2001
Aα(102)       
IVS3+1_+4del i-3 homozyg USA B12 a Neerman-Arbez M et al. 2001
   IVS3+1_+4del i-3 homozyg TURKEY C1 a Neerman-Arbez M et al. 2001   
IVS3+1_+4del i-3 homozyg IRAQUI (2 cases) a Yes No Erlacher M et al. 2009
g.1923_1926delGTAA (IVS3+1_+4delGTAA) i-3 homozyg IRAN P2 a? Asselta R et al. 2015
   g.1892-1899del i-3 compound SHANGHAI a Fang Y et al. 2003
2008 to 3245 deleted i-3 homozyg FUKUOKA a Yes No Watanabe K et al. 2003
   g.1978-3215del i-3 compound SHANGHAI a Fang Y et al. 2003
(c.364 + 86_510 +43 del1238) i-3 compound KURASHIKI II a Yes No Takezawa Y et al. 2012
(c.364 + 86_510 + 43del1238) i-3 homozyg YOKKAICHI a Yes No Takezawa Y et al. 2012
c.364+86_510+46del i-3 homozyg JAPAN a Yes Yes Nishihori M et al. 2022
c.364+1G>A i-3 homozyg INDIA BL-21 a Yes No Sumitha E et al. 2013
c.364+1G>A i-3 homozyg INDIA BL-348 h Yes No Sumitha E et al. 2013
c.364+1G>A i-3 homozyg INDIA BL-353 h Yes No Sumitha E et al. 2013
c.364+1G>A i-3 homozyg INDIA BL-369 a Yes No Sumitha E et al. 2013
c.364+1G>A i-3 homozyg INDIA BL-380 h No No Sumitha E et al. 2013
c.364+1G>A i-3 homozyg INDIA BL-535 h No No Sumitha E et al. 2013
c.364+4_364+7delAGTA i-3 compound ALGERIA (f8) a Hadjali-Saichi S et al. 2022
c.364+4_364+7delAGTA i-3 homozyg ALGERIA (f11) a Hadjali-Saichi S et al. 2022
Aα(103)       
Aα(104)Arg>Cys e-4 homozyg SOUTH ITALY H1 h No No Santacroce R et al. 2006
" e-4 heterozyg SOUTH ITALY H2 h No No Santacroce R et al. 2006
" g.3057C>T e-4 heterozyg CARACAS IX h No No Marchi R et al. 2018
Aα(106)Asn>Asp 5324A>G e-4 heterozyg PLZEN No Yes Kotlín R et al. 2009
Aα(108)Tyr>Cys p.Tyr127Cys c.380A>G e-4 heterozyg GERMANY h Yes No Sucker C et al. 2023
Aα(108)Tyr>stop p.Tyr127* c.381C>A e-4 homozyg INDIA BL-249 a Yes No Sumitha E et al. 2013
Aα(110)Arg>stop 3075C>T e-4 homozyg PALERMO, P4 a No Yes Asselta R et al. 2001
"    3075C>T e-4 homozyg BARBADOS, B1 a Yes No Asselta R et al. 2001
" p.Arg129X c.385C>T e-4 homozyg INDIA P4 (Mumbai) a Yes Monaldini L et al. 2007
" R129X c.385C>T e-4 compound MADAGASCAR a Yes No Tirefort Y et al. 2012
" p.Arg129stop g.3075C>T e-4 homozyg PAKISTAN P4 a Yes No Asselta R et al. 2015
" p.Arg129stop g.3075C>T e-4 homozyg PAKISTAN P9 a Yes No Asselta R et al. 2015
" p.Arg129stop g.3075C>T e-4 homozyg PAKISTAN P10 a Yes No Asselta R et al. 2015
Aα(110)Arg>Pro p.Arg129pro g.3076G>C e-4 heterozyg ITALY P16 h Yes Yes Asselta R et al. 2015   
Aα(112)Ser>Pro p.Ser131Pro c391T>C e-4 heterozyg GDANSK (4 cases) h Yes Yes Mital A et al. 2012
Aα(125)>frameshift-stop 3120-3122delAA e-4 homozyg DUTCH a Yes No Remijn JA et al. 2003
" 3121delAA e-4 compound BELGIUM A8 a Neerman-Arbez M et al. 2000
" 3121delAA e-4 compound FRANCE A12 a Neerman-Arbez M et al. 2000
Aα(126)Val>Asp p.Val145Asp c.434T>A e-4 heterozyg CHRISTCHURCH II (2 cases) h Yes No Brennan SO et al. 2017
" p.Val145Asp c.434T>A e-4 heterozyg IRAN 12 hd Yes No Mohsenian S et al. 2021
Aα(130)Arg>stop p.Arg149stop c.C464T e-4 homozyg INDIA P5, P13 a Yes Mukaddam A et al. 2015
Aα(131)Gln>stop Q150X 3108C>T e-4 homozyg SUSHOU a Yes No Wu S et al. 2005
Aα(141)Arg>Ser e-4     LIMA      Yes No Maekawa H et al. 1992   
Aα(143)Gln>stop p.Gln162stop g.3174C>T e-4 homozyg PAKISTAN P7 a? Yes No Asselta R et al. 2015
Aα(149)Arg>stop R168X CGA>TGA e-4 homozyg FRANCE B9 a Neerman-Arbez M et al. 2001   
" CGA>TGA e-4 homozyg NORWEGIAN / BAFFIN BAY a Yes No Fellowes AP et al. 2000
" p.Arg168Ter e-4 compound BONN a Yes Yes Berens C et al. 2016
" 3192C>T e-4 homozyg CAGLIARI, C9 a Yes No Asselta R et al. 2001
" 3192C>T e-4 homozyg SASSARI, S2 a Yes No Asselta R et al. 2001
" 3192C>T e-4 homozyg SASSARI, S3 a Yes No Asselta R et al. 2001
Aα(151)
IVS4+1G>T i-4 compound FRANCE a Yes No Angles-Cano E et al. 2007
IVS4+1G>T i-4 homozyg BELGIUM, A9 a Neerman-Arbez M et al. 2000
IVS4+1G>T i-4 compound BONN a Yes Yes Berens C et al. 2016
IVS4+1G>T i-4 homozyg FRANCE A2 a Neerman-Arbez M et al. 2000
IVS4+1G>T i-4 homozyg FRANCE A5 a Neerman-Arbez M et al. 2000
IVS4+1G>T i-4 homozyg FRANCE A6 a Neerman-Arbez M et al. 2000
IVS4+1G>T i-4 compound FRANCE A7 a Neerman-Arbez M et al. 2000
IVS4+1G>T i-4 compound FRANCE A10 a Neerman-Arbez M et al. 2000
   IVS4+1G>T i-4 homozyg FRANCE A11 a Neerman-Arbez M et al. 2001
IVS4+1G>T i-4 homozyg FRANCE B 1 a Neerman-Arbez M et al. 2000    
   IVS4+1G>T i-4 homozyg FRANCE B 11 a       Neerman-Arbez M et al. 2001   
IVS4+1G>T i-4 homozyg GRENOBLE, 2 cases a Yes No Polack B et al. 2010
   IVS4+1G>T i-4 compound KEOKUK (2 cases) h Yes Yes Lefebvre P et al. 2004
IVS4+1G>T i-4 compound UNITED STATES, B 3 a Neerman-Arbez M et al. 2000   
IVS4+1G>T i-4 compound UNITED STATES, B 4 a       Neerman-Arbez M et al. 2000    
IVS4+1 G>T i-4 homozyg SOUTH ITALY A3 a Yes Santacroce R et al. 2006
c.510+1G>T i-4 homozyg DUTCH a Yes Van Meegeren MER et al. 2014
c.510+1G>T i-4 homozyg BRON a Yes Yes Le Quellec S et al. 2018
c.510+1G>T i-4 compound CALGARY a Yes Yes Nathoo N et al. 2018
IVS4+1G>T i-4 compoud USA 1 a Yes No Smith N et al. 2018
c.510+1G>T i-4 compoud USA a Yes No Khan I et al. 2023
c.510+1G>T i-4 homozyg USA a yes No Parikh P et al. 2023
c.510+2T>G i-4 homozyg INDIA BL-569 a Yes No Sumitha E et al. 2013
c.511-216 15kb del i-4 isodisomy Thai a Yes Yes Spena S et al. 2004
Aα(152)                              
Aα(159)Arg>stop CGA>TGA e-5 compound GEELONG a Yes No Saravanan L et al. 2008    
" Arg178X g.3807C>T e-5 homozyg VENEZUELAN a Yes No Marchi-Cappelletti R et al. 2009
" C>T e-5 homozyg SOUTH ITALY A2 a Yes Yes Margaglione M et al. 2015
" p.Arg178Ter c.532C>T e-5 homozyg ITALY P1 a Yes Yes Chinni E et al. 2018
" p.Arg178* c.532C>T e-5 compound BRISTOL d Yes No Peck RC et al. 2021
Aα(159)>frameshift-stop g.3808-3809 ins.T e-5 homozyg NEW YORK (2 cases) a Yes Yes Chapin J et al. 2013
Aα(162)Arg>stop Arg181X c.541C>T e-5 homozyg PORTUGAL a Yes     Neerman-Arbez M et al. 2007    
" p.Arg181X c.541C>T e-5 compound LOS ANGELES, S3 a Yes No Young GA et al. 2018
Aα(164)>frameshift-stop p.Ser183Ilefs*7 c.546delGinsTATTAAGATCC e-5 homozyg ALGERIA (f12,f13) a Hadjali-Saichi S et al. 2022
Aα(165)Cys>Arg Cys184Arg c.550T>C e-5 heterozyg MULTINATIONAL d Yes Yes Casini A et al. 2015
Aα(165)Cys>Trp p.Cys184Trp g.3827C>G e-5 heterozyg ITALY P19 h No No Asselta R et al. 2015
Aα(169)Leu>frameshift-stop Leu188PhefsX4 c.563_564insT e-5 homozyg COLUMBIA a Yes     Neerman-Arbez M et al. 2007    
" p.Leu188PhefsX4 e-5 homozyg USA 2 a Yes No Smith N et al. 2018
Aα(181)Gln>stop p.Gln200stop g.3873C>T e-5 homozyg PAKISTAN P13 a? Yes No Asselta R et al. 2015
Aα(184)Gln>stop Gln203X     e-5 homozyg CHINESE 2 a Yes     Fang Y et al. 2006    
Aα(185)Leu>stop 3884_3885insTGA e-5 homozyg R79 a Yes No Monaldini L et al. 2005    
" Leu204X g.3884_3885insTGA; c.609_610 insTGA e-5 compound ITALY P2 (Palermo) a Yes     Monaldini L et al. 2007    
Aα(193)Leu>stop Leu212X c.635T>G e-5 homozyg LEBANON (2 cases) a Yes     Neerman-Arbez M et al. 2007    
Aα(192)Pro>Thr [203?] p.Pro222Thr e-5 heterozyg USA 15 d Yes No Smith N et al. 2018
Aα(217) c.711dup e-5 homozyg MOROCCAN a Yes Van Meegeren MER et al. 2015
Aα(219)Lys>stop 3983 insT e-5 homozyg ARNHEM a Yes No Vlietman JJ et al. 2002
Aα(221)Gln>stop p.Q240X c.718C>T e-5 homozyg EGYPTIAN (n=6) a Yes Wahab A et al. 2010
Aα(229)Trp>stop Trp248X c.743G>A e-5 homozyg BULGARIA a Yes Neerman-Arbez M et al. 2007
" p.Trp248X c.743G>A e-5 homozyg IRAN P5 (Shiraz) a Yes Monaldini L et al. 2007
Aα(243_244)Glu>frameshift158aa-stop p.Glu262fsX158 c.786_789 delGAGA e-5 homozyg MOROCCO a Yes Robert-Ebadi H et al. 2009
" p.Glu262_263 fs*158 c.786_789delGAGA e-5 homozyg INDIA BL-502 a Yes No Sumitha E et al. 2013
Aα(252)Arg>stop c.811C>T e-5 homozyg ZAGHOUAN a Yes No Amri Y et al. 2016
Aα(260)Thr>Pro frameshift142aa-stop g.4110delA e-5 compound FRANCE a Yes No Angles-Cano E et al. 2007
Aα(268)>Gln-Glu-Pro-stop 4133insC e-5 homozyg OTAGO h Yes No Ridgway HJ et al. 1997
Aα(270)Pro>Thr e-5 heterozyg SOUTH ITALY D2 (2 cases) d Yes No Santacroce R et al. 2006
Aα(272)ins39aa 4146ins(117bp) e-5  heterozyg   CHAMPAGNE AU MONT D'OR      No Yes Hanss M et al. 2001 A
Aα(276)Trp>stop Trp295X c.885G>A e-5 homozyg ALGERIA a Yes Neerman-Arbez M et al. 2007
" Trp295X c.885G>A e-5 homozyg Turkish (3 cases) a Yes Yes Rottenstreich A et al. 2016
'' p.Trp295* c.885G>A e-5 homozyg ALGERIA (f14,f15) a Hadjali-Saichi S et al. 2022
" p.Trp295Stop g.4160G>A e-5 homozyg LATINA P3 hd Yes No Asselta R et al. 2015
Aα(277)Asp>frameshift59aa-stop p.Asp296 fs*59 c.887_894dup7 e-5 homozyg INDIA BL-564 a Yes No Sumitha E et al. 2013
p.Ala307Val c.C920T e-5 homozyg INDIA P16 h Yes Mukaddam A et al. 2015
Aα(291) g.4179delA e-5 compound SWITZERLAND, B6 a Yes No Neerman-Arbez M et al. 2001
" Aα(310)fsX 4209delA e-5 homozyg IRAN 2 a Yes No Asselta R et al. 2002
Aα(293) (312)SerfsX42 c.934_935insA e-5 homozyg CHINESE a Xue F et al. 2009
" p.Ser312AlafsTer109 c.934delA e-5 homozyg P5 a Yes No Tavasoli B et al. 2020
" p.Ser312AlafsTer109 c.934delA e-5 homozyg P6 a Yes No Tavasoli B et al. 2020
Aα(297)Gly>stop G316X GGA>TGA e-5 compound FRANCE A7 a Neerman-Arbez M et al. 2000
Aα(297)Gly>Glu frameshift105aa-stop g.4190delT e-5 homozyg TURKEY B5 a Neerman-Arbez M et al. 2001
" g.4190delT e-5 homozyg LEBANON, C4 a Neerman-Arbez M et al. 2001
'' Aα(316) fsX105 4220delT e-5 homozyg IRAN 3 a Yes No Asselta R et al. 2002
" p.Gly316GlufsX105 g.4220delT e-5 homozyg BEOGRAD P1 a? Asselta R et al. 2015
" p.Gly316GlufsX105 c.945delT e-5 homozyg IRAN 13 a Yes No Mohsenian S et al. 2021
" p.Gly316GlufsX105 c.945delT e-5 homozyg P7 a Yes No Tavasoli B et al. 2020
" p.Gly316GlufsX105 c.945delT e-5 homozyg P8 a Yes No Tavasoli B et al. 2020
" p.Gly316GlufsX105 c.945delT e-5 homozyg P9 a Yes No Tavasoli B et al. 2020
" p.Gly316GlufsX105 c.945delT e-5 homozyg P10 a Yes No Tavasoli B et al. 2020
'' p.Gly316Glufs*105 c.945delT e-5 homozyg ALGERIA (f16) a Hadjali-Saichi S et al. 2022
Aα(300)Ala>frameshift39aa-stop 6477delA e-5 homozyg PODESIN a Yes No Stikarova J et al. 2013
Aα(312)Thr>Ala p.T331A e-5 non synonymous polymorphism Baumann RE et al. 1993
Aα(314)Ser>Cys g. 6540A>T e-5 compound SUMPERK II d Yes No Kotlin R et al. 2012
Aα(315)Trp>stop W334X e-5 compound FRANCE A12 a Neerman-Arbez M et al. 2000
" W334X g.g4277a e-5 homozyg TURKEY a Yes Yes Simsek I et al. 2008
'' p.Trp334* c.1001G > A e-5 homozyg NIJMEGEN a Yes Yes Saes JL et al. 2020
Aα(323)Gly>frameshift-stop Gly342GlufsX79 c.1025delG e-5 homozyg TUNISIA a Yes Neerman-Arbez M et al. 2007
" " c.1025delG e-5 heterozyg MADHIA (3 cases) hd Yes Yes Amri Y et al. 2017
Aα(327)Asn>frameshift-stop Asn346ThrfsX75 c.1037delA e-5 homozyg GERMANY a Yes Neerman-Arbez M et al. 2007
Aα(327)Asn>frameshift-stop p.Asn346Thrfs*75 c.1037del e-5 compound USA a Yes No Khan I et al. 2023
Aα(328)Gln>stop CAA>TAA e-5 compound KEOKUK (2 cases) h Yes Yes Lefebvre P et al. 2004
Aα(328)Gln>Pro 4315A>C e-5 heterozyg SEOUL II     Yes Park R et al. 2006
Aα(333)Pro frameshift-stop 4329delC e-5 compound UNITED STATES, B3 a       Neerman-Arbez M et al. 2000   
Aα(341)Trp frameshift-stop59 p.Trp360LeufsTer59 c.1078_1084delTGGAATC e-5 heterozyg Italian h Yes4 Yes Vilar R et al. 2020
Aα(373)Trp>stop p.Trp354* c.1119 G>A e-5 homozyg ITALY hd Yes No Castaman G et al. 2015
Aα(381)Ser>Phe c.1199C>T e-5 heterozyg AUSTIN d No No Brennan SO et al. 2015
Aα(434)Ser>Asn e-5     CARACAS II      No No Maekawa H et al. 1991
Aα(439)Arg>Cys p.Arg458Cys g.4647C>T e-5 heterozyg BORDEAUX      No Yes Hanss M et al. 2008
Aα(447)Thr>frameshift17aa-stop p.Thr466 fs*17 c.1398delT e-5 homozyg INDIA BL-376 a Yes No Sumitha E et al. 2013
Aα(452)Gly>Trp-Ser-stop    ATT>ATTT e-5 homozyg MILANO III      No Yes Furlan M et al. 1994
" Gly471Trpfs c.1410_1411insT e-5 heterozyg MULTINATIONAL d Yes No Casini A et al. 2015
" p.Gly471TrpfsX3 g.4685_4686insT e-5 heterozyg ITALY P7 hd Yes No Asselta R et al. 2015
Aα(453-454)Pro>stop CCTGAT>CCCTGA e-5 homozyg NIEUWEGEIN      No No Collen A et al. 2001
" p.Asp473Ter c.1415_1416 insC e-5 heterozyg Moroccan d No Yes Tajdar M et al. 2017
" p.Pro472ProfsX1 g.4689_4690insC e-5 homozyg MOROCCO P1 hd No No Asselta R et al. 2015
" p.Pro472ProfsX1 c.1415_1416 insC e-5 homozyg NIMES d No Yes Bouvier S et al. 2018
Aα(461)Lys>stop AAA>TAA e-5 homozyg MARBURG hd Yes Yes Koopman J et al. 1992     
" 4713A>T e-5     GIESSEN h Yes No Nielssen A et al. 2002 A
Aα(465)Thr>frameshift12aa-stop 4727delC e-5 heterozyg WILMINGTON Yes Brennan SO et al. 2006
Aα(467)Glu>stop 4731G>T e-5     CARACAS      Yes No Marchi R et al. 2001
" 4731G>T e-5 heterozyg GUARENAS      Yes     Marchi R et al. 2006
Aα(472)Cys>Ser C491S c.1472 G>C e-5 heterozyg SUMIDA (2 cases) hd No No Ikeda M et al. 2015
Aα(476)Met>4aa-stop 4758_4770del e-5 heterozyg LINCOLN (4 cases)      Yes No Brennan SO et al. 2002
Aα(476)Met>frameshift-stop Met495Hisfs c.1482-1495del e-5 homozyg MULTINATIONAL d No Yes Casini A et al. 2015
Aα(491)Arg>Cys p.Arg510Cys c.1528C>T e-5 heterozyg BONN (n=3) d Yes/No Yes/No Ivaškevičius V et al. 2023
Aα(494)His>frameshift-stop     4841delC e-5     PERTH      Yes No Homer VM et al. 2003
"     c.1541 delC e-5 heterozyg BRISTOL (5 cases) d No Yes Westbury SK et al. 2013
Aα(494)His>Pro-frameshift23aa C1537delA e-5 heterozyg MANNHEIM V No No Dempfle CE et al. 2009
Aα(496)Asp>Asn D515N c.G1543A e-5 heterozyg GRAND LYON III h Hanss M et al. 2007
" c.1543G>A e-5 compound MONTREAL h Yes No Campbell R et al. 2006
" p.Asp515Asn g.9860G>A e-5 ? CHINESE (2 cases) d Yes No Zhou J et al. 2015
Aα(499)Ala>frameshift-stop 1608delC e-5     SAN GIOVANNI ROTONDO      No No Margaglione M et al. 2001
" delC e-5 heterozyg SOUTH ITALY D3 (2 cases) d No No Santacroce R et al. 2006
" Ala518fs >Stop c.1608 delC e-5 Italian (2 cases) d Yes No Castaman G et al. 2019
Aα(517-522)delins31aa-stop 1636_1650del,1649_1650insCA e-5     SEOUL m No No Kang HG et al. 2005
Aα(519)Gly>Glu frameshift30aa-stop (p.G538E*30) c.1611delA e-5 heterozyg French m No No Rowczenio D et al. 2017
Aα(519)Gly>Arg p.Gly538Arg c.1612G>A e-5 homozyg MULTINATIONAL ? Rowczenio DM et al. 2014
Aα(519)Gly>Glu p.Gly538Glu c.1613G>A e-5 homozyg MULTINATIONAL ? Rowczenio DM et al. 2014
Aα(521)Phe>Ser frameshift27aa-stop p.Phe540Serfs*27 c.1619_1622delTTGT e-5 homozyg MULTINATIONAL m Rowczenio DM et al. 2014
'' (p.F540Sfs*27) c.1619_1622delTTGT e-5 heterozyg French m No No Rowczenio D et al. 2017
Aα(522-548)frameshift-stop 4897del e-5     PARIS VII m Hamidi Asl L et al. 1997
Aα(523)Ser>Arg frameshift24aa-stop c.4899_4902delAGTG e-5 heterozyg JAPAN m Yazaki M et al. 2015
Aα(524-548)frameshift-stop 4904del e-5     INDIANAPOLIS IV m Uemichi T et al. 1996
Aα(524)Glu>Lys p.Glu543Lys c.1627G>A e-5 homozyg MULTINATIONAL m Rowczenio DM et al. 2014
Aα(525)>frameshift c.1632delT e-5 heterozyg CHINESE m Gillmore JD et al. 2009
Aα(526)Glu>Lys p.Glu545Lys c.1633G>A e-5 homozyg MULTINATIONAL m Rowczenio DM et al. 2014
Aα(526)Glu>Val e-5     CHRISTCHURCH IV      No No George PM et al. 1996 A
" GAG>GTG e-5     INDIANAPOLIS II m No No Uemichi T et al. 1994
" GAG>GTG e-5     INDIANAPOLIS III m No No Uemichi T et al. 1996
" GAG>GTG e-5     LONDON IX      Gillmore JD et al. 2000
"     e-5     AUSTRALIA m Lane SW et al. 2006
"    e-5     No AA amyloidosis, 18 cases m Lachmann HJ et al. 2002
"      A>T e-5     PORTUGAL m       De Carvalho M et al. 2004  
" c.1577A>T e-5 heterozyg GERMAN, 3 cases m     Eriksson M et al. 2008
" e-5 heterozyg MONTPELLIER m     Gahide G et al. 2008
" e-5 heterozyg No AA amyloidosis, 46 cases m     Gillmore JD et al. 2009
" e-5 heterozyg PORTUGUESE m Delabre JP et al. 2009
" e-5 No AA amyloidosis, 21 cases m Stangou AJ et al. 2010
" Glu545Val e-5 NORTH AMERICAN (2 cases) m Zhen DB et al. 2014
" e-5 heterozyg CHINESE m Yao Y et al. 2014
" p.Glu545Val 4909A>T e-5 homozyg PORTUGAL m Yes No Tavares I et al. 2015
" p.Glu545Val c.1634A>T e-5 heterozyg BRAGA n=16 m Tavares I et al. 2017
" p.Glu545Val c.1634A>T e-5 heterozyg Portuguese (7), Brasilian (2) m Tavares I et al. 2019
" p.Glu545Val c.1634A>T e-5 heterozyg HUNGARY 12 ? No No Gindele R et al. 2021
'' p.E545V e-5 heterozyg POLAND m Ceglarz K et al. 2023
'' p.Glu545Val e-5 USA m Khaja T et al. 2023
Aα(528)Arg>Gly frameshift21aa-stop p. Arg547GlyfsTer21 c.1639delA e-5 heterozyg Chinese m No No Li D et al. 2019
'' p.Arg547Glyfs*21 c.1639delA e-5 heterozyg CHINA m Li ZY et al. 2022
Aα(532)Ser>Cys  TCT>TGT e-5 heterozyg CARACAS V      No Yes Marchi R et al. 2000
Aα(536)Thr>Val e-5 NORTH AMERICAN (2 cases) m Zhen DB et al. 2014
Aα(538)Thr>Lys c.1670C>A e-5 heterozyg CHINESE m Gillmore JD et al. 2009
Aα(539)>frameshift-stop p.Lys558Argfs*10 c.1673delA e-5 heterozyg CHINA m Li ZY et al. 2022
Aα(540)Glu>Val c.1676A>T e-5 heterozyg GERMAN, 2 cases m Gillmore JD et al. 2009
Aα(552)Pro>His c.1712C>A e-5 heterozyg CARIBBEAN m Gillmore JD et al. 2009
Aα(553)Ser>Leu e-5 NORTH AMERICAN m Zhen DB et al. 2014
Aα(554)Arg>Cys CGT>TGT e-5 heterozyg CHAPEL HILL III d No Yes Wada Y et al. 1994
'' CGT>TGT e-5 heterozyg DUSART / PARIS V (4 cases) d No Yes Koopman J et al. 1993
'' CGT>TGT e-5 HANNOVER II d No Yes Meyer M et al. 1999 A
'' CGT>CTT e-5 HANNOVER XI d No Yes Czwalinna A et al. 2001 A
'' CGT>TGT e-5 heterozyg NASHVILLE (11 cases) d No Yes Tarumi T et al. 2000
'' CGT>TGT e-5 heterozyg SCANDINAVIA (5 cases) d No Yes Ramanathan R et al. 2013
'' c.1717C>T e-5 heterozyg DALLAS d Yes Yes Shen YM et al. 2014
'' Arg573Cys c.1717G>C e-5 heterozyg MULTINATIONAL d No No Casini A et al. 2015
'' e-5 heterozyg SOUTH ITALY D4 (2 cases) d No Yes Santacroce R et al. 2006
Aα(554)Arg>Leu CGT>CTT e-5 INDIANAPOLIS m No No Benson MD et al. 1993
'' CGT>CTT e-5 PARIS VIII m No No Hamidi Asl L et al. 1998
'' CGT>CTT e-5 INDIANAPOLIS V m No No Uemichi T et al. 1998
'' e-5 heterozyg English (2 cases) m Gillmore JD et al. 2009
'' 4993G>T e-5 SPAIN (2 cases) m No No Haidinger M et al. 2013
'' 4993G>T e-5 LONDON m Stangou et al. 2010
'' e-5 NORTH AMERICAN m Zhen DB et al. 2014
Aα(554)Arg>His R573H G>A e-5 heterozyg SAN DIEGO V Yes Morris TA et al. 2009
'' (p.R573H) c.1718G>A e-5 heterozyg British m No No Rowczenio D et al. 2017
Aα(555)Gly>Phe p.Gly574Phe c.1720_1721delinsTT e-5 homozyg MULTINATIONAL m Rowczenio et al. 2014
'' (p.G574F) c.1720_1721delGGinsTT e-5 heterozyg Norwegian m No No Rowczenio D et al. 2017
Aα(556)Lys>frameshift74aa-stop p.Lys575 fs*74 c.1725 delA e-5 homozyg INDIA BL-273 a Yes No Sumitha E et al. 2013
Aα(572)>frameshift-stop p.Arg591Glufs*58 c.1771delA e-5 homozyg ALGERIA (f17) a Hadjali-Saichi S et al. 2022
Aα(581)>frameshift-stop p.Ser600Alafs*75 c.1798delA e-5 homozyg ALGERIA (f18) a Hadjali-Saichi S et al. 2022
Aα(587) p.Thr616HisfsX32 c.1846 del A e-5 heterozyg SOUTH SYRIA (7 cases) h No No Levrat E et al. 2011
'' p.Thr616HisfsX32 c.1846 del A e-5 homozyg SOUTH SYRIA (5 cases) a Yes Yes Levrat E et al. 2011
Aα(587)Thr>His frameshift32aa-stop Thr616HisfsX32 c.1846 del A e-5 homozyg Syrian a Yes Yes Lebreton A et al. 2014
Aα(559-625)delins72 578_644delins72 5011-5012delins10 e-5 heterozyg GRAND LYON h Yes No Hanss M et al. 2005
Aα(612)
i-5
Aα(612)
Aα(653)Trp>Arg 672Trp>Arg c.2014T>C e-6 compound Family 1 d No No Wan Y et al. 2021
Aα(710)Glu>Lys c.2185G>A e-6 heterozyg CHINA d No No Li S et al. 2020
'' p.Glu729Lys c.2185G>A e-6 heterozyg CHINA hd Chen Y et al. 2022
Aα(723)Phe>Tyr p.Phe742Tyr g.11246T>A e-6 Chinese d No No Zhou J et al. 2015
Aα(774)Trp>Gly p.Trp795Gly c.T2383G e-6 homozyg INDIA P15 h Yes Mukaddam A et al. 2015
AαE(790)Tyr>Cys c.2425A>G e-6 compound MONTREAL h Yes No Campbell R et al. 2006
AαAsn(820)Thr> p.Asn839Thr c.2516A>C e-6 heterozyg CHINA hd Ge S et al. 2023
Notes

NOTES :
Column 7 : « a »: afibrinogenemia, « d »: dysfibrinogenemia, « h »: hypofibrinogenemia, « hd »: hypodysfibrinogenemia, « m »: amyloidosis, « ? »: lack of evidence
Column 11 : « A » in case of observation mentioned in a congress abstract, « L » in a book chapter, « O » for on-line submission
The first author of the team reporting the molecular abnormality is mentioned
1 : post-partum DIC

2 : antifibrinogen
Renal amyloidosis : Indianapolis, Indianapolis II, Indianapolis III, Indianapolis IV, Indianapolis V, Paris VII, Paris VIII. These abnormalities belong to the Aa 522-554 region

3: associated with a protein S deficiency

4: associated with hemophilia A

Last update : 31/12/2023 temporary release 54 (24/04/2024)
GenBank access number : NG_008833.1

This update is partial.
Z. Sovova, MSc, PhD, should be acknowledged for her valuable assistance.

Abnormality
Plasma protein N-30 Native protein N Gene (as reported) e-i Gene status Name / Origin Type Haemorraghes Thromboses Authors
/ / interstitial deletion whole fibrinogen gene cluster compound FRANCE h No No Couzens A et al. 2022
Bβ(8)   
IVS1+2076g>a i-1 homozyg SRI LANKA  a Yes Yes Dear A et al. 2006  
Bβ(9)   
Bβ(9-72) del exon 2 deleted e-2 NEW YORK No Yes Liu C Y et al. 1985
Bβ(10)Phe>frameshift11aa-stop Phe40framshiftX52 g.2833_2834 ins.GTTT e-2 homozyg SUZHOU a Yes No Zhang J et al. 2014
Bβ(14)Arg>Cys CGT>TGT e-2 CHRISTCHURCH II No Yes Brennan SO et al. 1997
" CGT>TGT e-2 CHRISTCHURCH III No Yes Brennan SO et al. 1997
" CGT>TGT e-2 IJMUIDEN No Yes Koopman J et al. 1992
" CGT>TGT e-2 LONDON VIII    No Yes Vakalopoulou S et al. 1999
" CGT>TGT e-2 SEATTLE No No Pirkle H et al. 1987 L
"      e-2 HANNOVER XIX Yes      Czwalinna A 2003 O
" C>T e-2 VICENZA III No Yes Castaman G et al. 2005   
" e-2 heterozyg SAINT-GERMAIN III Yes de Raucourt E et al. 2006   
" p.Arg44Cys c.130C>T e-2 heterozyg UNITED KINGDOM d No Yes Shapiro SE et al. 2013
" Arg44Cys c.130C>T e-2 heterozyg MULTINATIONAL d No Yes Casini A et al. 2015
" Arg44Cys e-2 Italian (3 cases) d No Yes Castaman G et al. 2019
Bβ(15)Gly>Cys GGT>TGT e-2 FUKUOKA II No No Kamura T et al. 1995
" e-2 heterozyg HAMAMATSU II No Yes Kamijyo Y et al. 2009
" e-2 ISE No No Yoshida N et al. 1991
" 2815G>T e-2 KOSAI No Yes Hirota-Kawadobora M et al. 2003
" 2815G>T e-2 OGASA No No Hirota-Kawadobora M et al. 2003
" GGT>TGT e-2 heterozyg SHIZUOKA IV d Yes No Kibe T et al. 2013
" p.Gly45Cys c.133 GGT>TGT e-2 heterozyg KYOTO VII d No No Kaido T et al. 2021
Bβ(15)Gly>frameshift15aa-stop p.Gly45ValfsX15 c.134delG e-2 homozyg LOS ANGELES, S1 a Yes Yes Young GA et al. 2018
" p.Gly45ValfsX15 c.134delG e-2 homozyg LOS ANGELES, S2 a Yes No Young GA et al. 2018
Bβ(17)Arg>stop 3282C>T e-2 homozyg IRAN 1 a Yes No Asselta R et al. 2002
" R47X      e-2 compound GENEVA a Yes Yes Vu D et al. 2003
" 3282C>T e-2 compound ITALIAN h Yes Yes Asselta R et al. 2004 / Castaman et al. 2009
" e-2 compound FREIBURG a Czwalinna A 2004  O
"    e-2 compound SHANGAI a Yes    Fang Y et al. 2005   
" p.Arg47stop g.3282C>T e-2 homozyg PAKISTAN P6 a Yes No Asselta R et al. 2015
" p.Arg47stop g.3282C>T e-2 homozyg PAKISTAN P11 a Yes No Asselta R et al. 2015
" p.Arg47X c.139C>T e-2 compound LOS ANGELES, S4 a Yes No Young GA et al. 2018
Bβ(41)Tyr>stop 3356T>G e-2 heterozyg TOTTORI II h Yes No Mimuro J et al. 2003
Bβ(41)Tyr>Asn g.3354T>A e-2 heterozyg CARACAS VIII (2 cases) No No Marchi R et al. 2011
Bβ(44)Arg>Cys CGT>TGT e-2 NIJMEGEN No Yes Koopman J et al. 1992
" p.Arg74Cys c.220 CGT>TGT e-2 heterozyg IIDA II d No No Kaido T et al. 2021
Bβ(44)Arg>Gly c.220C>G e-2 heterozyg INNSBRUCK d Yes No Würtinger P et al. 2015
Bβ(44)Arg>Leu p.Arg74Leu c.221G>T e-2 heterozyg Kurdish (n=5) d No Yes Shlebak AA et al. 2016
Bβ(53)Lys>frameshift-stop Lys83IlefsX3 c.248_249delAGinsT e-2 homozyg SPAIN a Yes Neerman-Arbez M et al. 2007
Bβ(56)Glu>Lys c.256G>A e-2 heterozyg CHINA 21 h No No Zhou P et al. 2021
Bβ(58)Lys>frameshift41aa-stop 3404del A e-2 heterozyg CHRISTCHURCH V (3 cases) h Yes Yes Brennan SO et al. 2006
Bβ(61)Asp>Gly GAT>GGT e-2 heterozyg MIAMI Galanakis DK et al. 1996 and 2014 A
Bβ(65)Cys>Arg p.Cys95Arg g.3426T>C e-2 heterozyg GREECE P15 h? Asselta R et al. 2015
Bβ(65)Cys>Ser p.Cys95Ser c.284G>C e-2 heterozyg Moroccan (2 cases) hd Yes No Casini A et al. 2017
p.Cys95Ser c.284G>C e-2 heterozyg ITALY, P6 hd No No Chinni E et al. 2018
Bβ(65)Cys>Tyr c.284G>A e-2 heterozyg CHINA 17 hd Yes No Zhou P et al. 2021
Bβ(67)His>Leu 4864A>T e-2 heterozyg SUMPERK h Yes Kotlín R et al. 2008
Bβ(68)Ala>Thr GCT>ACT e-2 MILANO II = NAPLES No Yes Koopman J et al. 1992
" GCT>ACT e-2 SHIZUOKA No No Yonekawa O et al. 1997 A
" p.Ala98Thr g.8006G>A e-2 CHINESE (5 cases) d No Yes Zhou J et al. 2015
" GCT>ACT e-2 homozyg HAMAMATSU d No Yes Yoshida S et al. 2017
Bβ(68)Ala>Ser p.Ala98Ser c.292G>T e-2 heterozyg SVETEC (P2, n=2) d Yes/No No Ceznerová E et al. 2022
Bβ(68)Ala>Asp p.Ala98Asp c.293C>A e-2 heterozyg CHINA (n=5) d No No Jia K et al. 2023
Bβ(72)   
i-2   
Bβ(73)   
Bβ(88)Glu>stop p.Glu118X c.352C>T e-3 compound DANISH a Yes No Casini A et al. 2014
Bβ(111)Ser del 3590_3592del e-3 KYOTO IV No No Okumura N et al. 2005
Bβ(118)Met>Lys M148K 4075T>G e-3 heterozyg LYON (2 cases) h Yes Yes Hanss M et al. 2005
Bβ(121)Leu>Arg p.Leu151Arg ? c.452T>G ? e-3 heterozyg WHENZOU h No No Zhang H et al. 2019
Bβ(134)Asp>Ser frameshift33aa-stop c.490G>A e-3 heterozyg KYOTO IX (2 cases) h No No Taira C et al. 2017
Bβ(134)   
i-3   
Bβ(134)   
Bβ(137Asn-141Glu) del Asn167-Glu171del c.498_512del e-4 heterozyg EPSOM (3 cases) hd Yes No Brennan SO et al. 2009
Bβ(140)Asn>Lys p.N170K c.510T>A e-4 compound KOBE I hd Yoda M et al. 2020
Bβ(148)Lys>Asn   e-4 compound MERIVALE II h Yes No Maghzal GJ et al. 2003
" c.534 G>C e-4 compound CAVERSHAM (2 cases) h Yes No Brennan SO et al. 2014
Bβ(150)Gln>Stop Bβ(180)Gln>Stop g.9661C>T [c.538C>T] e-4 homozyg MARTIN a Yes No Stanciakova L et al. 2015
" " e-4 heterozyg MARTIN (n= 4) h No No Simurda T et al 2016
Bβ(157)Val>frameshift-stop p.Val187GlufsTer2 c.560_561delTG e-4 compound Chinese ? No No Wang X et al. 2020
Bβ(160)Asn>Ser TAA>TGA e-4 NIIGATA No No Sugo T et al. 1999 A
" p.Asn190Ser g.9692A>G e-4 CHINESE (6 cases) d Yes No Zhou J et al. 2015
" p.(Asn190Ser) c.569 A>G e-4 heterozyg SURESNES V d No No Vasse M et al. 2019
Bβ(162)Pro>Gln frameshift-stop p.Pro192Glnfs*13 [CCC>CAA] c.574delCC e-4 homozyg TAIWAN 1 a Yes No Shen MC et al. 2021
" p.Pro192Glnfs*13 [CCC>CAA] c.574delCC e-4 heterozyg TAIWAN 1 (n=3) ? No No Shen MC et al. 2021
Bβ(165)Leu>Pro CTT>CCT e-4 LONDON, GC Yes No Mitchell M et al. 2002 A
Bβ(166)Arg>Cys CGT>TGT e-4 LONGMONT d Yes No Lounes KC et al. 2000
" c.586C>T e-4 heterozyg SHEFFIELD d No Yes van Vulpen LFD et al. 2018
" Arg196Cys c.586C>T e-4 heterozyg MULTINATIONAL d Yes No Casini A et al. 2015
" e-4 heterozyg SOUTH ITALY D5 (3 cases) d No No Santacroce R et al. 2006
" p.Arg196Cys g.9709C>T e-4 CHINESE d No No Zhou J et al. 2015
" p.Arg196Cys c.586C>T e-4 heterozyg ITALY, P3 d No No Chinni E et al. 2018
" p.Arg196Cys c.586C>T e-4 heterozyg SLOVAKIA F1 (n=4) d Yes/No No Simurda T et al. 2020
" (p.Arg196Cys) c.586C>T e-4 heterozyg HUNGARY 14 (n=2) d Yes/No No Gindele R et al. 2021
" p.Arg196Cys c.586C>T e-4 heterozyg LONGMONT (n=2) d Yes/No No Leung J et al. 2022
Bβ(172)Leu>Gln    5157T>A e-4 compound ITALIAN h Yes No Asselta R et al. 2004
Bβ(184)Ser>Leu frameshift59aa-stop p.Ser214LeufsX59 g.5193delC e-4 homozyg IRAN P12 a Asselta R et al. 2015
Bβ(185)Asp>Asn p.Asp215Asn g.5195G>A e-4 heterozyg CHINA P4 d Yes Yes Asselta R et al. 2015
Bβ(189)Glu>Arg p.Glu219Arg e-4 heterozyg USA 21 h No No Smith N et al. 2018
Bβ(197)Cys>Arg Cys227Arg c.679T>C e-4 homozyg SFAX hd Yes No Amri Y et al. 2016
'' Cys227Arg c.679T>C e-4 heterozyg SFAX (n=6) hd No Yes Amri Y et al. 2016
Bβ(197)Cys>Phe p.Cys227Phe c.680G>T e-4 homozyg SOUTHERN ITALY a Yes No Grandone E et al. 2012
Bβ(197)Cys>Ser frameshift45aa-stop Cys227Ser frameshift45aa-stop c.680delG e-4 heterozyg SWISS d Yes No Priovolos A et al. 2015
Bβ(204)Pro>Leu p.P234L c.701C>T e-4 heterozyg Japanese h No No Kaido T et al. 2020
Bβ(209)   
IVS4-1G>C i-4 compound Danish a Yes No Casini A et al. 2014   
Bβ(210)   
Bβ(219_223)Gly_Glu del p.Gly249_Glu253del c.745_759delGGTGAAACATCTGAA homozyg Thai h Yes No Rakmanotham A et al. 2020
Bβ(235)Pro>Leu C>T e-5 non synonymous polymorphism Brennan SO et al. 2000
Bβ(236)Tyr>stop 5909T>G e-5 LOZANNE No Yes Hanss M et al. 2003
Bβ(236)Tyr>Cys Y266C 5909A>G e-5 compound PARIS IX h Yes Yes Horellou MH et al. 2006
Bβ(237)Arg>Ser 7344A>T e-5 heterozyg ZNOJMO d Yes Yes Kotlin R et al. 2010
Bβ(243)Asn c.819_820insT e-5 homozyg INDIA P11 a Yes Mukaddam A et al. 2015
Bβ(245)Glu>stop p.(Glu275*) c.823G>T e-5 homozyg ALGERIA (f19) a Hadjali-Saichi S et al. 2022
Bβ(247)   
IVS5+2T>A i-5 heterozyg ITALY h No Yes Castaman G et al.2015   
Bβ(248)   
Bβ(248)Gly>Glu p.(Gly278Glu) c.833G>A e-6 homozyg ALGERIA (f20) a Hadjali-Saichi S et al. 2022
Bβ(255)Arg>Cys e-6 HANNOVER XV Yes No Czwalinna A et al. 2002 A
" e-6 HANNOVER XVI No Yes Czwalinna A et al. 2002 A
Bβ(255)Arg>His 6654G>A e-6 HANNOVER XII a Yes No Czwalinna A et al. 2001 A
" 6654G>A e-6 compound MERIVALE II h Yes No Maghzal GJ et al. 2003
" 6654G>A e-6 heterozyg MERIVALE (4 cases) h Yes No Maghzal GJ et al. 2003
" p.Arg285His c.854G>A e-6 heterozyg Swedish h Yes No Fager Ferrari M et al. 2020
Bβ(258)Gly>Ser p.Gly288Ser c.862G>A e-6 homozyg INDIA BL-247 a Yes No Sumitha E et al. 2013
" p.Gly288Ser c.682G>A [c.862?] e-6 heterozyg ITALY, P5 h No No Chinni E et al. 2018
" p.(Gly288Ser) c.862G>A e-6 homozyg ALGERIA (f21) a Hadjali-Saichi S et al. 2022
Bβ(264)Arg>Gly    c.882A>G [c.880?] e-6 heterozyg NOTTINGHAM II h Yes Hill MB et al. 2006
Bβ(264)Arg>Ser p.Arg294Ser c.882G>C e-6 heterozyg Swiss (2 cases) h No No Casini A et al. 2017
Bβ(266)Trp>stop Trp296X c.887G>A e-6 homozyg ITALY, P3 (Sardinia) a Yes Monaldini L et al. 2007
Bβ(269)Tyr>His p.Tyr299His c.895T>C e-6 homozyg Algerian a Yes Yes Casini A et al. 2014
" p.(Tyr299His) c.895T>C e-6 homozyg ALGERIA (f22) a Hadjali-Saichi S et al. 2022
Bβ(272)Gly>Arg p.Gly302Arg c.904G>C e-6 homozyg ROSARIO a Yes No Ivaškevicius V et al. 2016
" p.Gly302Arg c.904G>C e-6 heterozyg ROSARIO (n=3) h No No Ivaškevicius V et al. 2016
" p.Gly302Arg e-6 heterozyg USA 22 h No No Smith N et al. 2018
Bβ(272)Gly>Glu p.(Gly302Glu) c.905G>A e-6 heterozyg ALGERIA (f23,24,25) a Hadjali-Saichi S et al. 2022
Bβ(277)Ala>Val Ala307Val c.764C>T ? e-6 heterozyg FOXTON (h) No No Davis RL et al. 2008
Bβ(277)Ala>Ser p.Ala307Ser c.919G>T e-6 homozyg NORTHERN ITALY a No Yes Grandone E et al. 2012
Bβ(289)
IVS6+1G>A i-6 heterozyg AVON h Homer V et al. 2002
c.958+1G>A i-6 compound LOS ANGELES, S4 a Yes No Young GA et al. 2018
IVS6+13C>T  i-6 homozyg IRAN 3 a Yes Spena S et al. 2002
IVS6-10_16del i-6 compound MATSUMOTO IX h No No Terasawa F et al. 2010
c.959-10_16delTTTG i-6 heterozyg BIZERTE h Yes Yes Amri Y et al. 2020
IVS6-9del4 i-6 LONDON, MM Yes No Mitchell M et al. 2002 A
Bβ(290)
Bβ(293)Trp>stop Trp323X g.6977G>A e-7 homozyg SHANGHAI a Yes Yes OuYang Q et al. 2012 O
Bβ(295)Gly>Ala c.974G>C e-7 homozyg RDEYEF a Yes No Amri Y et al. 2016
" c.974G>C e-7 heterozyg RDEYEF (n=5) h No No Amri Y et al. 2016
Bβ(295)Gly>Arg p.Gly325Arg c.973G>A e-7 heterozyg P2 Finnish h No No Bartolo R et al. 2021
Bβ(303)Ser c.989-999delinsCCAGG e-7 homozyg MUMBAI 2 d No No Patil R et al. 2016
Bβ(316)Asp>Tyr GAC>TAC e-7 heterozyg HAMILTON (2 cases) h Yes No Brennan SO et al. 2001
Bβ(326)Tyr>Cys Y356C c.1067A>G e-7 heterozyg VILLEURBANNE II (2 cases) h Yes Hanss M et al. 2007
" (p.Tyr356Cys) c.1067A>G e-7 heterozyg HUNGARY 20 (n=4) h Yes/No Yes/No Gindele R et al.2021
" p.Tyr356Cys c.1067A>G e-7 heterozyg VILLEURBANNE II hd No Yes Francisco BJ et al. 2022
Bβ(335)Ala>Thr    e-7 PONTOISE       Kaudewitz H et al. 1986 L
Bβ(338)Tyr>His Tyr368His c.1102T>C e-7 homozyg MARTIN II h No Yes Simurda T et al. 2018
" Tyr368His c.1102T>C e-7 heterozyg MARTIN II (3cases) h No Yes Simurda T et al. 2018
Bβ(338)Tyr>Cys p.Tyr368Cys c.1103A>G e-7 heterozyg P1 France h No No Bartolo R et al. 2021
Bβ(339)Gln>stop c.1105C>T e-7 heterozyg CARACAS (2 cases) h Yes No Marchi R et al. 2013
Bβ(342)Val>Glu p.Val372Glu c.1115T>A e-7 heterozyg CHINA (n=2) d Wang X et al. 2022
Bβ(345)Tyr>stop p.Tyr375* c.1125C>A e-7 homozyg TRINEC (P3) a No No Ceznerová E et al. 2022 <
Bβ(345)Tyr>Cys p.Tyr375Cys e-7 heterozyg USA 24 h No No Smith N et al. 2018
Bβ(347)Gly>Arg e-7 LONDON, LB Yes No Mitchell M et al. 2002 A
" e-7 compound SHANGAI a Fang Y et al. 2005
Bβ(351)Asn>Lys 8578T>A e-7 heterozyg ROKYCANY h No No Kotlin R et al. 2010
Bβ(353)Leu>Arg 7156T>G e-7 homozyg Afibrinogen MILANO a Yes No Duga S et al. 2000
p.Thr378Ile c.C1133T e-7 homozyg INDIA P10 h Yes Mukaddam A et al. 2015
Bβ(375)Tyr>Cys e-7 ADELPHI d No No Galanakis DK et al. 2014
Bβ(377)Thr>Lys p.Thr407Lys g.7228C>A e-7 homozyg PAKISTAN P8 a? Yes No Asselta R et al. 2015
Bβ(384)Gly>frameshift2aa-stop p.Gly414fs*2 c.1241del G e-7 homozyg INDIA BL-01 a? Yes No Sumitha E et al. 2013
Bβ(385)                     
       IVS7+1G>T i-7 homozyg ITALY 2 a No No Spena S et al. 2002
       IVS7+1G>C i-7 compound PARIS IX h Yes Yes Horellou MH et al. 2006
IVS7+1G>T i-7 compound ITALY, P4 hd No Yes Chinni E et al. 2018
c.1244+1G>A i-7 heterozyg Armenian h Yes No Casini A et al. 2017
9aa 416-424stop OR 15aa 416-43024stop c.1245-17_1262 del OR c.1245-16_1263 del i-7 coumpound KOBE I hd Yoda M et al. 2020
Bβ(386)                     
Bβ(393)Gln>stop Q423X nt.7893C>T e-8 heterozyg patient A, VICENZA (4 cases) h Yes No Castaman G et al. 2008
Bβ(400)Gly>Arg p.Gly430Arg c.1288G>C e-8 homozyg Iranian, 13 a Yes No Tavasoli B et al. 2020
Bβ(400)Gly>Asp 7915G>A e-8 homozyg afibrinogen MILANO II a Yes No Duga S et al. 2000
" p.Gly430Asp c.1289G>A e-8 homozyg Iranian, 11 a Yes No Tavasoli B et al. 2020
" p.Gly430Asp c.1289G>A e-8 homozyg Iranian, 12 a Yes No Tavasoli B et al. 2020
Bβ(401)Gly>Val c.1292C>T e-8 heterozyg KOGARAH (3 cases) hd Yes No Brennan SO et al. 2011
Bβ(402)Trp>stop W432X 7919A>G e-8 heterozyg LYON II (2 cases) h No No Hanss M et al. 2005
Bβ(403)Trp>Leu p.Trp433Leu c.1298G>T e-8 heterozyg Swiss (3 cases) h No No Casini A et al. 2017
Bβ(403)Trp>stop TGG>TAG e-8 heterozyg Japanese h Shinozuka J et al. 2021
" p.Trp433* c.1298G>A e-8 heterozyg MOST (P4) h No Yes Ceznerová E et al. 2022
" p.Trp433Stop c.1299G>A e-8 heterozyg NANNING h? Yan J et al. 2021
Bβ(403)Trp>Cys p.(Trp433Cys) c.1299G>T e-8 homozyg ALGERIA (f26) a Hadjali-Saichi S et al. 2022
Bβ(407)Cys>stop c.1311T>A e-8 heterozyg ST KILDA (2 cases) h Yes No Aung NN et al. 2015
Bβ(413)Asn>Ser  Asn443Ser c.1328A>G e-8 heterozyg NEW LYNN h Yes No Davis RL et al. 2009
Bβ(413)Asn>Lys p.Asn443Lys c.1329C>G e-8 heterozyg Turkish h Yes No Casini A et al. 2017
Bβ(414)Gly>Ser G444S      e-8 compound GENEVA a Yes Yes Vu D et al. 2003
" e-8 HANNOVER XVIII Yes No Czwalinna A et al. 2002 A
" e-8 HANNOVER XX No No Czwalinna A 2003 O
" 9348G>A e-8 heterozyg UNICOV h? No No Kotlín R et al. 2008
" p.Gly444Ser c.1330G>A e-8 heterozyg POLAND (P5,P6) h Yes Yes Weronska A et al. 2022
" p.Gly444Ser c.1330G>A e-8 heterozyg POLAND (P9) h No Yes Weronska A et al. 2022
" p.Gly444Ser c.1330G>A e-8 heterozyg POLAND (P7,P8) h No No Weronska A et al. 2022
" p.(Gly444Ser) c.1330G>A e-8 heterozyg GERMANY h No No Sucker C et al. 2022
Bβ(414)Gly>Ala  Gly444Ala c.1331G>C e-8 heterozyg PAPAMOA h Yes Davis RL et al. 2009
Bβ(415)Arg>Thr p.Arg445Thr c.1334G>C e-8 homozyg INDIA BL-267 h Yes No Sumitha E et al. 2013
" p.Arg445Thr c.1334G>C e-8 homozyg INDIA BL-377 a Yes No Sumitha E et al. 2013
Bβ(416)Tyr>Cys p.Tyr446Cys c.1337A>G e-8 heterozyg KARLOVY VARY (P4) h No No Ceznerová E et al. 2022
Bβ(419)Gly>frameshift16aa-stop 7972delG e-8 homozyg ANHUI h Yes Xu XC et al. 2006
Bβ(434)Gly>Asp 8017G>A e-8 homozyg MUMBAI h Yes    Monaldini L et al. 2006
" p.Gly464Asp c.G1391A e-8 homozyg INDIA P6 a Yes Yes Mukaddam A et al. 2015
Bβ(437) W467X TGG>TAG e-8 homozyg PALESTINIAN (2cases) a Yes No Neerman-Arbez M et al. 2003
Bβ(437)Trp>Gly    8025T>G e-8 homozyg IRAN 2 a Yes    Spena S et al. 2003
Bβ(440)Trp>stop 8035G>A e-8 heterozyg MOUNT EDEN h Yes No Homer VM et al. 2002
Bβ(442)Gly>Val p.Gly472Val c.1415G>T e-8 homozyg PORTUGUESE h No Yes Casini A et al. 2014
Bβ(443)Ser>stop p.Ser473* c.1418C>G e-8 heterozyg CHINA h Jia KQ et al. 2023
Bβ(444)Trp>stop (p.Trp474Ter) c.1421G>A e-8 heterozyg MARTIN IV h Yes No Simurda T et al. 2020
'' (p.Trp474*) c.1421G>A e-8 heterozyg HUNGARY 26 h yes Yes Gindele R et al. 2021
Bβ(446)Ser>stop (p.Trp476*) c.1427C>T e-8 homozyg ALGERIA (f27,28,29,30) a Hadjali-Saichi S et al. 2022
Bβ(448)Arg>Lys p.R478K e-8 non synonymous polymorphism Baumann RE et al. 1993
Bβ(455)Arg>Lys p.Arg485Lys e-8 heterozyg USA 23 h Yes No Smith N et al. 2018
Bβ(462)extension 12aa-stop TAG>AAG e-8 heterozyg OSAKA VI Yes No Sugo T et al. 2000
'' p.ter492Glnext*12 c.1474T>C e-8 heterozyg TAIWAN 2 and 3 (n=4) d No No Shen MC et al. 2021
'' p.ter492Glnext*12 c.1474T>C e-8 heterozyg TAIWAN 4 (n=2) d Yes Yes Shen MC et al. 2021
" X492Trp ext12aa-Stop 8101A>G e-8 heterozyg MAGDEBURG II d Yes No Franke K et al. 2002 A
" X492Trp ext12aa-Stop c.1475A>G e-8 heterozyg SEOUL d? No No Woo HI et al. 2012
" TAG>TGG e-8 heterozyg KYOTO VI Yes No Okumura N et al. 2012
Bβ(462)Ter>Gln ext Ter492Gln e-8 Italian (5 cases) hd Yes No Castaman G et al. 2019
Notes

NOTES :
Column 7 : « a »: afibrinogenemia; « d » :dysfibrinogenemia; « h »: hypofibrinogenemia; « hd »: hypodysfibrinogenemia; « ? »: lack of evidence
Column 11 : « A » in case of observation mentioned in a congress abstract, « L » in a book chapter, « O » for on-line submission
The first author of the team reporting the molecular abnormality is mentioned

 

Last update : 31/12/2021 - release 53
GenBank access number : NG_008834.1

Abnormality
Plasma protein N-26 Native protein N Gene (as reported) e-i Gene status Name / Origin Type Haemorraghes Thromboses Authors
γ(-1)       
IVS1+5G>A i-1 homozyg PAKISTANI a Yes No Asselta R et al. 2000
IVS1+5 G>C i-1 heterozyg BELCHATOW h Yes No Wypasek E et al. 2019
γ(+1)       
g.194delA e-2 homozyg MOROCCO C2 a Neerman-Arbez M et al. 2001
γ(15)                  
IVS2+1G>A i-2 & WAIKATO h Yes No Wyatt J et al. 2000
g.2018G>A (IVS2+1G>A) i-2 homozyg IRAN P3 a Yes No Asselta R et al. 2015
IVS2-3C>T i-2 homozyg PAKISTANI B2 a Neerman-Arbez M et al. 2001
IVS2-3C>G i-2 homozyg AMIENS a Yes No Malaquin S et al. 2016
IVS2-2A>C i-2 heterozyg ZAKOPANE h No No Wypasek E et al. 2019
IVS2-1G>A i-2 homozyg Iraqui (2 cases) a Yes Yes Rottenstreich A et al 2016
γ(16)
c.123+9T>A e-3 compound INDIA P2 d Yes Mukaddam A et al. 2015
γ(16)Gly>Ser p.Gly42Ser c.124G>A e-3 heterozyg KRAKOW III d Yes No Pietrys D et al. 2011
γ(21)Thr>Ile c.140C>T e-3 heterozyg ZLIN (2 cases) h No No Riedelova-Reicheltova Z et al. 2014
" p.Thr47Ile c.140C>T e-3 compound ITALY, P4 hd No Yes Chinni E et al. 2018
γ(23)Cys>stop γ(49)Cys>X c.147delT147_149insACA e-3 heterozyg SHIZUOKA III h Soya K et al. 2013
γ(55)Ser>frameshift5aa-stop p.Ser81fs*5 c.243delA e-3 homozyg INDIA BL-379 a Yes No Sumitha E et al. 2013
γ(66)Leu>Phe (p.Leu92Phe) c.274C>T e-3 nsp Yan J et al. 2021
γ(76)
IVS3+5G>A i-3 homozyg NAPOLI a Yes No Margaglione M et al. 2000
IVS3-2A>G i-3 compound MATSUMOTO IX h No No Terasawa F et al. 2010
g.2394A>G (IVS3+4A>G) i-3 heterozyg ITALY P18 h? No No Asselta R et al. 2015
γ(77)    
γ(78)Met c.311_312del e-4 compound INDIA P2 d Yes Mukaddam A et al. 2015
γ(82)Ala>Gly e-4     HANNOVER XVII Yes No Czwalinna A et al. 2002 A 
" e-4     HANNOVER XXVI h Czwalinna A 2004 O 
" e-4     HANNOVER XXVII h Czwalinna A 2004 O 
" c.323C>G e-4     FRANKFURT XIV h No No Ivaskevicius V et al. 2005
" c.323C>G e-4 FRANKFURT XV h No No Ivaskevicius V et al. 2005
" e-4 compound WAIKATO h Yes No Wyatt J et al. 2000
" GCT>GGT e-4     DUNEDIN h Yes No Brennan SO et al. 2000
" 778C>G e-4 heterozyg NEW ZEALAND 1 h Brennan SO et al. 2006   
" " e-4 " NEW ZEALAND 2 h Yes Brennan SO et al. 2006
" " e-4 " AUSTRALIA h Yes Brennan SO et al. 2006
"     " e-4 " GERMANY h Yes Brennan SO et al. 2006
" C2525G e-4 compound LEIPZIG II hd Yes No Meyer M et al. 2007   
" e-4 heterozyg Polish h Yes Zdziarska J et al. 2009
" p.Ala108Gly e-4 heterozyg USA 4 d No No Smith N et al. 2018
" p.A108G e-4 heterozyg CORDOBA h No Yes (note2) Guglielmone HA et al. 2019
γ(85)Lys>stop p.Lys111X c.331A>T e-4 heterozyg POZNAN (3 cases) h Yes Zawilska K et al. 2010
" p.Lys111X e-4 compound USA 3 a Yes Yes Smith N et al. 2018
γ(98)Ala>Lys Ala124Lys c.370_371delGCinsAA GCT>AAT e-4 heterozyg TAIWAN 5 d Yes No Shen MC et al. 2021
γ(105)Ile>Thr Ile131Thr e-4 Italian d Yes No Castaman G et al. 2019
γ(108)Arg>stop γ(134)Arg>X G804C>T e-4 homozyg LEBANON (10 cases) a Yes Neerman-Arbez M et al. 2004   
γ(108)
γ(109)    
γ(114)Tyr>His Y140H T>C e-5 compound SAN DIEGO II Yes Morris TA et al. 2009
" c.418T>C e-5 compound MICHIGAN (3 cases) hd Yes Yes Brennan SO et al. 2013
γ(124)Leu>stop Leu150X c.448delC e-5 homozyg FRANCE a Yes Neerman-Arbez M et al. 2007
γ(124)Leu p.150 c.449_464del e-5 homozyg INDIA P3 h Yes Mukaddam A et al. 2015
γ(139)Cys>Tyr e-5 PRETORIA Matsuda M et al. 1999 A
γ(139)Cys>Arg p.Cys165Arg c.493T>C e-5 compound BAISE h Yes No Zhou W et al. 2018
γ(151)    
i-5    
γ(152)    
γ(152)del-end del47645-62872 e-6 THAILAND a      Duga S et al. 2003 A
γ(153)Cys>Arg e-6 MATSUMOTO IV h No No Terasawa F et al. 1999
γ(159)Lys>frameshift13aa-stop p.Lys185fs*13 c.554del A e-6 homozyg INDIA BL-80 a Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554del A e-6 homozyg INDIA BL-176 a? Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554del A e-6 homozyg INDIA BL-219 a? Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554delA e-6 homozyg INDIA BL-228 h? Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554del A e-6 homozyg INDIA BL-239 a? Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554del A e-6 homozyg INDIA BL-248 a? Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554delA e-6 homozyg INDIA BL-375 a Yes No Sumitha E et al. 2013
" p.Lys185fs*13 c.554delA e-6 homozyg INDIA BL-556 a Yes No Sumitha E et al. 2013
γ(165)Gly>Arg GGG>AGG e-6 HANNOVER XIV h Yes No Czwalinna A et al. 2001 A
" 4682G>A e-6 MILANO XII No No Bolliger-Stucki B et al.2001
"      e-6 HANNOVER XXI No No Czwalinna A 2003 O
ɣ(165)Gly>Val p.Gly191Val c.572G>T e-6 heterozyg ITALY, P7 h No No Chinni E et al. 2018
γ(181)Tyr>Cys Tyr207Cys c.620A>G e-6 heterozyg MULTINATIONAL (3 cases) d Yes Yes Casini A et al. 2015
γ(196)   
IVS6+23T>A (c.666+23T>A) i-6 homozyg BEJA h Yes Yes Amri Y et al. 2020
   IVS6-320A>T g.5438A>T i-6 homozyg Afibrinogen VICENZA (2 cases) a Yes Yes Spena S et al. 2007
IVS6-320A>T g.5838A>T i-6 heterozyg VENETO h No Yes Plate M et al. 2009
del 5716_5892 i-6 heterozyg POZNAN II d Yes No Wypasek E et al. 2019
ISV6-12A>G i-6 compound USA 3 a Yes Yes Smith N et al. 2018
c.667-1G>C i-6 homozyg SAO PAULO a Yes No Virmond et al. 2020
γ(197)
γ(197)Arg>stop R223X e-7 homozyg PUERTO RICO, A4 a Neerman-Arbez M et al. 2001
" R223X    e-7 homozyg HISPANIC a Yes Yes Fuchs RJ et al. 2007
γ(200)Gly>Val c.677G>T e-7 heterozyg COLUMBUS h Yes Davis RL et al. 2007
" c.677G>T e-7 heterozyg Syrian (4 cases) h ? ? Rottenstreich A et al 2016
γ(204)Phe>Val 5529T>C e-7 heterozyg HRANICE h No No Kotlin R et al. 2014
γ(208)Trp>Leu g.5792G>T e-7 heterozyg WENZHOU (4 cases) h No No Zhu L et al. 2014
ɣ(208)Trp>Arg Trp234Arg e-7 Italian d No No Castaman G et al. 2019
γ(211)Tyr>His c.709T>C e-7 compound CAVERSHAM (2 cases) h Yes No Brennan SO et al. 2015
γ(213)Glu>Ala p.Glu239Ala c.A716C e-7 homozyg INDIA P9 d Yes Mukaddam A et al. 2015
γ(216)Gly>Glu c.725G>A e-7 heterozyg CARACAS (2 cases) h No No Marchi R et al. 2016
" p.Gly242Glu c.725G>A e-7 heterozyg French Basque h yes No Bauduer F et al. 2018
γ(227)Trp>Cys W253C TGG>TGT e-7 BRATISLAVA h Yes No Vu D et al. 2005   
γ(228)Leu>Leu c.760C>T e-7 compound BRISBANE h Yes Yes Brennan SO et al. 2016
γ(229)Gly>Glu c.764G>A e-7 compound BRISBANE h Yes Yes Brennan SO et al. 2016
γ(230)Asn>His N256H 5857A>C e-7 heterozyg LYON IV h No No Hanss M et al. 2005   
γ(230)Asn>Asp AAT>GAT e-7 MIDDLEMORE h Yes No Brennan SO et al. 2005   
γ(230)Asn>Lys p.Asn256Lys g.5859T>G e-7 heterozyg PIACENZA P2 hd Yes No Asselta R et al. 2015
γ(231)Glu>stop    5860G>T e-7 homozyg HAKATA a Iida H et al. 2000
γ(232)Lys>Thr g.5864 A>C e-7 heterozyg WENZHOU (5 cases) h Yes No Zhu L et al. 2014
" 5864 A>C e-7 heterozyg CHINA (5 cases) h Wang Y et al. 2015
γ(239)Gln>His CAG>CAT e-7 VICENZA Yes No Castaman G et al. 2005   
ɣ(249)Glu>stop p.Glu275Stop c.823G>T e-7 heterozyg MARTIN III h No Yes Simurda T et al. 2019
γ(252-253)Asp> frameshift17aa-stop p.Asp278-279 fs*17 c.834_835del CT e-7 homozyg INDIA BL-474 a Yes No Sumitha E et al. 2013
γ(253)Trp>Cys Trp279Cys c.837G>C e-7 heterozyg MULTINATIONAL d No Yes Casini A et al. 2015
γ(253)Trp>Gly c.835T>G e-7 homozyg DARLINGHURST h Yes Yes Shen CR et al. 2006
γ(258)    
c.851+1G>A i-7 homozyg INDIA BL-478 a Yes No Sumitha E et al. 2013
γ(258)    
γ(262)Tyr>Cys 7187A>G e-8 heterozyg LIBEREC Yes No Kotlín R et al. 2008
γ(268)Gly>Glu GGA>GAA e-8 KURASHIKI No No Niwa K et al. 1996
γ(275)Arg>Cys e-8 BALTIMORE IV No No Schmelzer CH et al. 1989   
" C823T e-8 heterozyg BELLINGHAM (7 cases) d No Yes Linenberger ML et al. 2000
" e-8 BOLOGNA No Yes Haverkate F et al. 1995   
" 7475C>T e-8 heterozyg CEDAR RAPIDS No Yes Siebenlist KR et al. 2000
" CGC>TGC e-8 FUKUSHIMA No No Imafuku Y et al. 2002
" CGC>TGC e-8 HANNOVER IV Yes No Meyer M et al. 2000 A
" CGC>TGC e-8 HANNOVER IX Czwalinna A et al. 2001 A
" CGC>TGC e-8 HANNOVER X Czwalinna A et al. 2001 A
" e-8 HANNOVER XXX Czwalinna A 2004 O
" e-8 compound HERSHEY IV Yes No Flood VH et al. 2008
" p.Arg301Cys e-8 heterozyg LEUVEN (5 cases) d No Yes Jacquemin M et al. 2017
" CGC>TGC e-8 heterozyg MATSUMOTO III No No Terasawa F et al. 1999
" CGC>TGC e-8 MILANO V No No Steinmann C et al. 1994
" e-8 heterozyg MORIOKA No No Terukina S et al. 1987 A
" CGC>TGC e-8 heterozyg OSAKA II d No No Terukina S et al. 1987/1988
" e-8 heterozyg PORTLAND Yes No Rein CM et al. 2010
" CGC>TGC e-8 heterozyg SENDAI Kamijyo Y et al. 2009
" e-8 TOCHIGI No No Yoshida N et al. 1988
" e-8 TOKYO II No No Yamazumi K et al. 1988
" CGC>TGC e-8 VILLAJOYOSA No Yes Borrell M et al. 1995
" p.Arg301Cys c.901C>T e-8 heterozyg UNITED KINGDOM d No No Shapiro SE et al. 2013
" c.901C>T e-8 BELGIUM d No No Depoorter M et al. 2014
" Arg301Cys c.902G>C e-8 heterozyg MULTINATIONAL (33 cases) d Yes Yes Casini A et al. 2015
" e-8 heterozyg SOUTH ITALY D6-8 (6 cases) d No No Santacroce R et al. 2006
" Arg301Cys CGC>TGC e-8 heterozyg CHINA P1 (2 cases) d Yes No Bin Q et al. 2015
" p.Arg301Cys g.10818C>T e-8 CHINESE (13 cases) d Yes No Zhou J et al. 2015
" Arg301Cys e-8 Italian (2 cases) d No No Castaman G et al. 2019
" p.Arg301Cys e-8 P14 d No No Marchi R et al. 2021
" p.Arg301Cys e-8 P15 d Yes No Marchi R et al. 2021
" p.Arg301Cys c.901C>T e-8 heterozyg IRAN 4 d Yes No Mohsenian S et al. 2021
" p.Arg301Cys c.901C>T e-8 heterozyg IRAN 9 d Yes No Mohsenian S et al. 2021
" p.Arg301Cys c.901C>T e-8 heterozyg IRAN 10 d Yes No Mohsenian S et al. 2021
" p.Arg301Cys c.901C>T e-8 heterozyg IRAN 11 hd Yes No Mohsenian S et al. 2021
" c.901C>T e-8 heterozyg CHINA 12 d No No Zhou P et al. 2021
" c.901C>T e-8 heterozyg CHINA 13 d No No Zhou P et al. 2021
γ(275)Arg>His CGC>CAC e-8 BARCELONA III No Yes Borrell M et al. 1995
" e-8 BARCELONA IV No No Borrell M et al. 1995
" e-8 BERGAMO II No Yes Reber P et al. 1986
" e-8 heterozyg CHINESE Ouyang Q et al. 2011
" e-8 CLARO No No Steinmann C et al. 1996
" 7476G>A e-8 heterozyg CORDOBA Yes No Guglielmone HA et al. 2008
" Arg301His e-8 heterozyg CRETE (3 cases) No No Travlou A et al. 2010
" e-8 ESSEN No No Reber P et al. 1986
" e-8 HAIFA No Yes Kehl M et al. 1984
" CGC>CAC e-8 heterozyg IIDA Kamijyo Y et al. 2009
" e-8 OSAKA III No No Yoshida N et al. 1992
" CGC>CAC e-8 heterozyg OTSU II Kamijyo Y et al. 2009
" e-8 PERUGIA No No Reber P et al. 1986
" e-8 SAGA Yes No Yamazumi K et al. 1988
" CGC>CAC e-8 heterozyg SHIZUOKA Kamijyo Y et al. 2009
" C>A e-8 SURESNES Mathonnet F et al. 1999 A
" g.5678G>A e-8 SHANGAI Fang Y et al. 2005
" 7476G>A e-8 heterozyg BRNO Yes No Kotlín R et al. 2008
" c.902G>A e-8 heterozyg ZABRZE No No Undas A et al. 2010
" p.Arg301His c.902G>A e-8 heterozyg UNITED KINGDOM (3 cases) d Yes No Shapiro SE et al. 2013
" p.Arg301His c.902G>A e-8 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
" p.Arg301His c.902G>A e-8 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
" Arg301His c.902G>A e-8 heterozyg MULTINATIONAL (19 cases) d Yes Yes Casini A et al. 2015
" p.Arg301His g.10819G>A e-8 CHINESE (20 cases) d Yes No Zhou J et al. 2015
" g.7476G>A e-8 heterozyg CHINESE d Jiang L et al. 2018
" p.Arg301His e-8 heterozyg USA 5, USA 6 d No Yes Smith N et al. 2018
" p.Arg301His e-8 heterozyg USA 7 d No Yes Smith N et al. 2018
" p.Arg301His e-8 heterozyg USA 8 d No No Smith N et al. 2018
" p.Arg301His e-8 heterozyg USA 9 d Yes No Smith N et al. 2018
" p.R301H c.902G>A e-8 heterozyg BEIJING, P2 d No No Cao Z et al. 2019
" Arg301His e-8 Italian (2 cases) d No Yes Castaman G et al. 2019
" p.(Arg301His) c.902 G>A e-8 heterozyg SURESNES VI (2 cases) d No No Vasse M et al. 2019
" p.Arg301His e-8 P10 d No note 3 Marchi R et al. 2021
" p.Arg301His e-8 P11 d Yes note 3 Marchi R et al. 2021
" p.Arg301His e-8 P12 d Yes note 3 Marchi R et al. 2021
" p.Arg301His e-8 P13 d Yes note 3 Marchi R et al. 2021
" c.902 G>A e-8 heterozyg CHINA 9 d Yes No Zhou P et al. 2021
" c.902 G>A e-8 heterozyg CHINA 10 d No Yes Zhou P et al. 2021
" c.902 G>A e-8 heterozyg CHINA 11 d Yes No Zhou P et al. 2021
" p.Arg301His c.902 G>A e-8 heterozyg HUNGARY 16 d Yes No Gindele R et al 2021
" p.Arg301His c.902 G>A e-8 heterozyg HUNGARY 17 d No No Gindele R et al 2021
" p.Arg301His c.902 G>A e-8 heterozyg HUNGARY 18 d Yes No Gindele R et al 2021
" p.Arg301His c.902 G>A e-8 heterozyg HUNGARY 19 d No No Gindele R et al 2021
γ(275)Arg>Ser CGC>AGC e-8 KAMOGAWA No No Mimuro J et al. 1999
γ(277)Thr>Arg 7482G>C e-8 heterozyg WENZHOU (3 cases) h No No Zhu L et al. 2013
γ(277)Thr>Pro p.Thr303Pro g.7481A>C e-8 compound FINLAND P21 (4 cases) h Yes Yes Asselta R et al. 2015
γ(278)Tyr>His Tyr304His TAT>CAT e-8 heterozyg HIROSHIMA h Yes No Kamijo T et al. 2021
γ(279)Ala>Asp GCC>GAC e-8 heterozyg AUCKLAND d Yes No Brennan SO et al. 2000
" Ala305Asp e-8 Italian (3 cases) d Yes No Castaman G et al. 2019
γ(280)Tyr>Cys TAC>TGC e-8 heterozyg BANKS PENINSULA d Yes No Fellowes AP et al. 1998
" Tyr306Cys c.917A>G e-8 heterozyg MULTINATIONAL (2 cases) d No Yes Casini A et al. 2015
γ(281)Phe>Leu c.921C>G e-8 heterozyg CHINA 14 d No No Zhou P et al. 2021
γ(284)Gly>Arg GGG>CGG e-8 heterozyg BRESCIA (8 cases) h, fsd Yes No Brennan SO et al. 2000
" GGG>AGG e-8 heterozyg GERMANY (2 cases) h, fsd Yes No Puls F et al. 2013
γ(289)Ala>Asp p.Ala315Asp e-8 heterozyg USA 10, USA 11 d Yes Yes Smith N et al. 2018
γ(289)Ala>Val GCC>GTC e-8 heterozyg DORFEN (2 cases) h Yes No Dear A et al. 2004
" GCC>GTC e-8 heterozyg KANAZAWA III (2 cases) hd Yes No Kaido T et al. 2020
γ(289)del3aa delCCTTTGATG e-8 heterozyg CHINESE hd Zhu L et al. 2018
γ(292)Gly>Val GGC>GTC e-8 BALTIMORE Yes Yes Bantia S et al. 1990
" GGC>GTC e-8 SAINT GALLEN Yes No Stücki B et al. 1999
γ(295)Phe>frameshift40aa-stopVal c.963del frameshift e-8 heterozyg COLUMBUS III h Yes No Abdelghani E et al. 2021
γ(301)Asp>His p.Asp327His g.7553G>C e-8 compound FINLAND P21 (4 cases) h Yes Yes Asselta R et al. 2015
γ(305)Thr>Ala T331A c.1132A>G ? e-8 heterozyg NAGAKUTE hd No No Ikeda M et al. 2014
γ(307)His>Tyr CAT>TAT e-8 heterozyg MANNHEIM II h No No Dear A et al. 2004
ɣ(307)His>Arg p.His333Arg c.998A>G e-8 heterozyg ITALY, P8 h Yes No Chinni E et al. 2018
" p.His333Arg c.998 A>G e-8 heterozyg ŁODZ d No Yes Treliński J et al. 2019
γ(308)Asn>Ile e-8 heterozyg BALTIMORE III d No No Bantia S et al. 1990
γ(308)Asn>Lys AAT>AAG e-8 heterozyg BICÊTRE II d No Yes Grailhe P et al. 1993
" AAT>AAG e-8 KYOTO d No No Yoshida N et al. 1988
" AAT>AAG e-8 heterozyg MATSUMOTO II d Yes No Okumura N et al. 1996
" AAT>AAG e-8 MATSUMOTO VI No No Terasawa F et al. 2000
" AAT>AAG e-8 heterozyg NAGANO (2 cases) d No No Kirihara T et al. 2014
γ(308)Asn>Thr c.1001A>C e-8 homozyg HANGZHOU (2 cases) d No No Liao Z et al. 2013
" p.Asn334Thr g.10918A>C e-8 CHINESE d No No Zhou J et al. 2015
γ(309)Gly>Asp GCC>GAC e-8 HILLSBOROUGH No No Mullin JL et al. 2002
γ(309)Gly>Cys p.Gly335Cys g.10920G>T e-8 CHINESE (2 cases) d No No Zhou J et al. 2015
γ(310)Met>Thr ATG>ACG e-8 heterozyg ASAHI d Yes No Yamazumi K et al. 1989
" e-8 FRANKFURT VII Yes No Miesbach W et al. 2009
"      e-8 HANNOVER XXIX Czwalinna A 2004 O
" p.Met336Thr c.1007T>C e-8 heterozyg YECHEON d Yes No Park E et al. 2009
" 7581T>C e-8 heterozyg TOKUSHIMA II (2 cases) d Yes No Shigekiyo T. et al 2012
γ(313)Ser>Asn    7590G>A e-8 h Meyer M et al. 2006   
γ(313)Ser>Arg c.1015A>C e-8 heterozyg DETROIT II hd Yes Brennan SO et al. 2009
γ(313)Ser>Gly 7339A>G e-8 heterozyg PRAHA IV d Yes Yes Kotlin R et al. 2014
γ(313)Ser>Ile 7590G>T e-8 heterozyg CHINESE h Zhu L et al. 2018
γ(314)Thr>Ile 5846C>T e-8 heterozyg KAGOSHIMA hd Yes Niwa K et al. 2007
" (p.Thr340Ile) c.1019C>T e-8 heterozyg Chinese h? Yes Yes Nie H et al. 2020
γ(314)Thr>Pro c.1018C>A e-8 heterozyg AL DUPONT h, fsd No No Brennan SO et al. 2010
γ(316)Asp>His g.7598G>C e-8 heterozyg WENZHOU h No No Wang Y et al. 2014
γ(316)Asp>Asn p.Asp342Asn c.1024G>A e-8 heterozyg PISA (3 cases) h, fsd No No Asselta R et al. 2015
γ(316)Asp>Gly p.Asp342Gly c.1025A>G e-8 heterozyg UNITED KINGDOM (3 cases) d Yes No Shapiro SE et al. 2013
γ(316)Asp>Glu-(343-344 duplication) p.Asp342Glu;Asn343-Asp344 duplication c.1026C>A1027-1032 duplication e-8 heterozyg ITALY, P10 h Yes No Chinni E et al. 2018
γ(318)Asp>Tyr GAC>TAC e-8 BASTIA No No Lounes KC et al. 1999
γ(318)Asp>Gly e-8 GIESSEN IV Yes Yes Haverkate F et al. 1995
" A>G e-8 Meyer M et al. 2000 A
γ(318)Asp>Val Asp344Val c.1031A>T e-8 heterozyg CAEN No Yes Robert-Ebadi H et al. 2008
γ(319)Asn>Asp p.Asn345Asp g.7607A>G e-8 heterozyg ITALY P20 h Asselta R et al. 2015
γ(319)Asn>Lys T>A e-8 Meyer M et al. 2000 A
γ(319)Asn del     e-8 HANNOVER XXII h   Czwalinna A 2004 O
γ(319-320) del AATGAT deleted e-8 VLISSINGEN= FRANKFURT IV No Yes Koopman J et al. 1991
" deletion e-8 OTSU No No Terasawa F et al. 2003
γ(320)Asp del delGAT e-8 heterozyg DES MOINES (3 cases) hd Yes Yes Brennan SO et al. 2007
" c.1036-1038 del e-8 compound MICHIGAN (3 cases) hd Yes Yes Brennan SO et al. 2013
γ(320)Asp>Glu p.346 Asp>Glu c.1038T>A e-8 heterozyg WHAKATANE hd Yes No Brennan SO et al. 2015
γ(320)Asp>Gly nt.7611GAT>GGT e-8 heterozyg CHINESE, patient B h No No Castaman G et al. 2008
" p.346 Asp>Gly c.1037A>G e-8 heterozyg OKAYAMA II hd No No Mukai S et al. 2015
γ(320)Asp>Ala e-8 ATHENS III d No No Galanakis DK et al. 2014
γ(322)Phe>Cys TTT>TGT e-8 VILLEURBANNE No No Hanss M et al. 2000 A
γ(322)Phe>Ile p.Phe348Ile c.1042T>A e-8 heterozyg BEIJING (2 cases) d Yes No Hua B et al. 2015
γ(325)Asn>Ile Asn351Ile c.1052A>T e-8 heterozyg KRAKOW h Yes No Undas A et al. 2009
γ(326)Cys>Ser e-8 CORDOBA Yes No Guglielmone HA et al. 2004
" 7628G>A e-8 HANNOVER XIII No Yes Czwalinna A et al. 2001 A
" TGT>TCT e-8 heterozyg TOKAI hd No Yes Ushijima A et al. 2017
" p.Cys352Ser e-8 heterozyg USA 12 d No Yes Smith N et al. 2018
γ(326)Cys>Tyr G7629A e-8 heterozyg SUHL (2 cases) d      Yes Meyer M et al. 2003
" TGT>TAT e-8 FROSTBURG hd No Yes Dear A et al. 2005
γ(326)Cys>Phe c.1055G>T e-8 heterozyg MELBOURNE (2 cases) hd No Yes Cheah CY et al. 2012
γ(327)Ala>Thr 5884G>A e-8 TOKYO V No Yes Hamano A et al. 2004
γ(327)Ala>Val p.Ala353Val c.1058C>T e-8 heterozyg CHINA d No No Wei A et al. 2021
γ(329)Gln>Arg e-8 NAGOYA No No Miyata T et al. 1989
γ(329)Gln>Lys c.1063C>A e-8 heterozyg CHINA 19 hd Yes No Zhou P et al. 2021
γ(330)Asp>Tyr GAT>TAT e-8 KYOTO III No No Terukina S et al. 1989
γ(330)Asp>Val GAT>GTT e-8 ALES No Yes Lounes KC et al. 2000
" e-8 MILANO No No Reber P et al. 1986
" Asp356Val c.1067A>T e-8 heterozyg MULTINATIONAL (3 cases) d Yes No Casini A et al. 2015
" p.Asp356Val c.1067A>T e-8 heterozyg ITALY, P9 d No Yes (note 1) Chinni E et al. 2018
γ(332)Ser>Cys Ser358Cys c.1073C>G e-8 heterozyg MULTINATIONAL (2 cases) d Yes Yes Casini A et al. 2015
ɣ(333)Gly>Cys p.Gly359Cys c.1075G>T e-8 heterozyg COLUMBUS II hd No Yes Kumar R et al. 2019
γ(335)Trp>Cys e-8 DANVILLE d No Yes Galanakis DK et al. 2014
γ(336)Met>Ile G7660A e-8 heterozyg HANNOVER VI      Yes Meyer M et al. 2003
"      e-8 HANNOVER XXIII h      Czwalinna A 2004 O 
γ(336)Met>Lys (p.Met362Lys) c.1085T>A e-8 heterozyg HUNGARY 27 No Yes Gindele R et al. 2021
γ(337)Asn>Lys e-8 BERN No No Steinmann C et al. 1993
γ(339)Cys>Ser p.Cys365Ser c.1094G>C e-8 heterozyg PEGASUS BAY (2 cases) h Yes No Brennan SO et al. 2015
" Cys365Asp e-8 Italian hd Yes No Castaman G et al. 2019
γ(339)Cys>frameshift41 p.Cys365Phefs41* c.1094delG e-8 heterozyg BAISE h Yes No Zhou W et al. 2021
γ(340)His>frameshift40 p.His366ThrfsTer40 c.1096delC e-8 homozyg P 14 a Yes No Tavasoli B et al. 2020
γ(340)His>Asn p.His366Asn c.1096C>G e-8 heterozyg ANKARA (2 cases) h, fsd No No Callea F et al. 2017
γ(340)His>Arg c.1097A>G e-8 heterozyg NANCHANG hd No No Peng Y et al. 2020
γ(341)Ala>Thr A367T c.1099G>A e-8 heterozyg LYON III (2 cases) h Hanss M et al. 2007
" p.Ala367Thr c.1099G>A e-8 heterozyg UNITED KINGDOM d Yes No Shapiro SE et al. 2013
γ(341)Ala>Asp GTC>GAT e-8 heterozyg SEOUL          Yes Song KS et al. 2006
γ(341)Ala>Val c.1100C>T e-8 heterozyg TOLAGA BAY h Yes No Davis RL & Brennan SO 2008
" p.Ala367Val g.11017C>T e-8 CHINESE d No Yes Zhou J et al. 2015
γ(341)Ala>Pro e-8 STONY BROOK VII d Yes No Galanakis DK et al. 2014
ɣ(344)Leu>Phe Leu370Phe e-8 Italian (6 cases) hd Yes No Castaman G et al. 2019
γ(345)Asn>Asp A7685G e-8 heterozyg STUTTGART (2 cases) h No No Meyer M et al. 2003
γ(345)Asn>Ser 7687A>G e-8 heterozyg SAINT GERMAIN II (2 cases) h No Yes de Raucourt E et al. 2005
" g.7686A>G e-8 heterozyg ITALY, proband 2 h Yes No Platè M et al. 2008
γ(346-350) del g.del7690_7704 e-8 heterozyg ANGERS h, fsd Dib N et al. 2007
γ(350)    
c.1129+62_65delAATA i-8 compound TSUKUBA hd No No Mukai S et al. 2017
γ(351)    
γ(351)Gly>14aa ins GGT>GTT e-9 PARIS No No Rosenberg JB et al. 1993
γ(351)Gly>Ser GGT>AGT e-9 heterozyg PRAHA h Yes Kotlin R et al. 2007
" G377S G7703A e-9 compound LEIPZIG II hd Yes No Meyer M et al. 2007
γ(352)Gly>Cys c.1132G>T e-9 compound ILAM (2 cases) h Yes No Brennan SO et al. 2011
γ(353)Thr>Pro c.1135A>C e-9 compound ILAM (2 cases) h Yes No Brennan SO et al. 2011
γ(354)Tyr>Cys A9351G e-9 heterozyg HOMBURG VII      Yes Meyer M et al. 2003
γ(357)Ala>Thr e-9 heterozyg FRANKFURT (5 cases) Yes Miesbach W et al. 2009
γ(358)Ser>Cys TCT>TGT e-9 heterozyg MILANO VII (6 cases) d No No Steinmann C et al. 1994
" Ser384Cys e-9 Italian d No No Castaman G et al. 2019
γ(361)Asn>Lys 9373T>A e-9 POISSY II      Mathonnet F et al. 2003
γ(363)Tyr>Asn 9127T>A e-9 heterozyg PRAHA III No Yes Kotlín R et al. 2009
γ(364)Asp>His GAT>CAT e-9 MATSUMOTO No No Okumura N et al. 1996
γ(364)Asp>Val e-9 MELUN No Yes Bentolila S et al. 1995
γ(364)Asp>Asn c.1168G>A e-9 heterozyg CHINA 15 d No No Zhou P et al. 2021
γ(364)Asp>frameshift-stop c.1169_1170delAT e-9 heterozyg OTA h No No Nagata K et al. 2017
γ(365)Asn>Lys Asn391Lys c.1173T>A e-9 heterozyg MULTINATIONAL d Yes No Casini A et al. 2015
γ(366)Gly>Ser p.Gly392Ser c.1174G>A e-9 heterozyg BEOGRAD (3 cases) h, fsd No No Asselta R et al. 2015
γ(367)Ile>Thr c.1178T>C e-9 heterozyg CHINESE d Yes No Luo S et al. 2020
γ(369)Trp>Leu p.Trp395Leu g.12739G>T e-9 CHINESE (2 cases) d Yes No Zhou J et al. 2015
γ(371)Thr>Ile ACT>ATT e-9 MUNCIE h Yes Brennan SO et al. 2001
" e-9 TRABZON fsd, h? No No Burcu G et al. 2020
γ(375)Arg>Gly e-9 OSAKA V No No Yoshida N et al. 1992
γ(375)Arg>Trp CGG>TGG e-9 AGUADILLA (3 cases) h, fsd Brennan SO et al. 2002
" CGG>TGG e-9 GENEVA h Rubbia-Brandt L et al. 2006
" p.Arg401Trp c.1201C>T e-9 heterozyg GENEVA II h, fsd Casini A et al. 2015
" c.1201C>T e-9 heterozyg ITALIAN h Francalanci P et al. 2006
" R401W C>T e-9 compound SAN DIEGO h Yes Morris TA et al. 2009
" e-9 heterozyg Japanese (2 cases) h Sogo T et al. 2009
" p.Arg401Trp g.9413C>T e-9 heterozyg ITALY P17 h No No Asselta R et al. 2015
" CGG>TGG e-9 heterozyg GERMANY (6 cases) h, fsd No No Puls F et al. 2013
" p.Arg401Trp c.1201C>T e-9 heterozyg TURKEY (5 cases) h, fsd No No Sari S et al. 2015
" e-9 heterozyg TURKEY h, fsd No No Callea F et al. 2017
" p.Arg401Trp c.1201C>T e-9 heterozyg SWITZERLAND (3 cases) h Yes Yes Casini A et al. 2015
" e-9 heterozyg SOUTH ITALY H3 h No No Santacroce R et al. 2006
'' p.Arg401Trp c.1201C>T e-9 heterozyg Chinese fsd, h No No Gu L et al. 2020
ɣ(375)Arg>Leu p.R401L c.1202G>T e-9 heterozyg BEIJING, P3 d No No Cao Z et al. 2019
γ(376)Trp>stop γ(402)Trp>X c.1205G>A e-9 heterozyg KANAZAWA II h Soya K et al. 2013
γ(378)Ser>Pro TCC>CCC e-9 PHILADELPHIA hd Yes No Keller MA et al. 2005
γ(380)Lys>Asn AAG>AAT e-9 KAISERSLAUTERN No Yes Ridgway HJ et al. 1997
γ(387)Ile>frameshift-stop g.7651 delA e-9 heterozyg MATSUMOTO VII h No No Fujihara N et al. 2010
γ(407)
IVS9-154T>C i-9 compound MONTREAL h Yes No Campbell R et al. 2006
p.Val434Serfs*29 g.IVS9+1delG i-9 heterozyg CHINESE (4 cases) d Yes No Huang D et al. 2015
γ(408)
γB(408)Arg>frameshift-stop p.R435fs* c.1299+4delA compound TSUKUBA hd No No Mukai S et al. 2017
γ(411)Val>Ile compound HERSHEY IV Yes No Flood VH et al. 2008
Notes

NOTES :
Column 7 : « a »: afibrinogenemia; « d »: dysfibrinogenemia; « h »: hypofibrinogenemia; « hd »: hypodysfibrinogenemia; « m »: amyloidosis; « fsd »: fibrinogen storage disease; « ? »: lack of evidence
Column 11 : « A » in case of observation mentioned in a congress abstract, « L » in a book chapter, « O » for on-line submissionThe first author of the team reporting the molecular abnormality is mentioned

1 : post-partum DIC

2 : compound heterozygote for protein C deficiency

3: one of the patients P10, P11, P12 and P13 presents with thromboembolism

 

Base de données Fibrinogène

Human Fibrinogen Database

Présentation

Recommandations des sociétés savantes

Et documents de référence du GFHT

Nos recommandations

Annuaire des membres

Retrouvez la liste complète des membres du GFHT et leurs coordonnées

Membres du GFHT